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Abstract 
Growth hormone (GH) can produce a multitude of biological actions on 
vertebrates including promotion of body growth, stimulation of intermediary 
metabolism and transcription regulation of specific genes. These biological actions are 
mediated via growth hormone receptor (GHR) on the target tissues. The target cells 
responsive to GH contain the membrane bound GHR. Similar to other cytokine 
receptors, the signal transduction event is initiated by one GH binding to two GHRs to 
form a dimer of receptors. There is relatively little knowledge of GH and GHR in 
lower vertebrates. Therefore, the aim of my project is to use frog {Xenopus laevis) and 
goldfish {Carassius auratus) as animal models to study the GH and GHR in lower 
vertebrates. 
In amphibian, the cDNA sequence of GHR (xGHR) and two isoforms of GH 
(xGH-A and xGH-B) were isolated from Xenopus laevis. The sequence of xGHR was 
found to contain 2507bp including a coding region that encodes for 603 amin acids. In 
adult, the xGHR is highly expressed in the liver and kidney. This GHR is 
subsequently expressed in mammalian cells (CH0-K1). The expressed xGHR 
responded to hGH to induce cell proliferation. The cDNA sequence of xGH-A 
encodes a protein of214 amino acid residues while xGH-B contained 208 amino acid 
residues. These two xGHs were expressed in a prokaryotic expression system. After 
i 
purification, two proteins around 20kDa in size were obtained. 
The goldfish GHR (gfGHR) cDNA was isolated from the pituitary and brain 
cDNA library. Within the 2566bp ofgfGHR sequence, 1806bp is the coding region 
which encodes for 602 amino acid residues. Liver, kidney and hypothalamus were 
found to be the major tissues that express the receptor in goldfish. The coding region 
of gfGHR was subcloned and functionally expressed. This receptor can induce cell 
proliferation upon stimulation by hGH, and is able to transactivate a co-expressed 
mammalian serine protease inhibitor (Spi) 2.1 promoter luciferase upon addition of 











對爪蟾0^ «0；?«_5 /«6”/>?0和金魚(02^^/««? auratus) 0只和01^基因和蛋白表達的 
硏究’期望對兩棲類和魚類GH和GHR的表達特徵與其份子生物學有進一步的 
瞭解。 
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Chapter 1 Introduction 
Chapter 1 General Introduction 
1.1. Growth hormone (GH) 
1.1.1. Introduction to GH 
The relationship between the pituitary gland and somatic growth was first 
demonstrated in ablation experiments by Ascher at 1912 (1). Subsequently, the bovine 
pituitary exacts was found to promote growth (2). At 1945, the growth factor in the 
soluble protein faction was isolated from the bovine pituitary gland (3). This factor 
was called growth hormone (GH) or somatotropin. Until 1971，the complete amino 
acid sequence of human GH (hGH) was determined by Li and Dixon (4). After that 
the functions and the sequences of GH from different species were studied. 
GH, together with prolactin, placental lactogen or chorionic somatomamotropin 
are members of a large family of homologous polypeptide hormones. In a variety of 
species, GHs are encoded by genes that span approximately 2,0kb that contain five 
exons and four introns. The translation start codon is located in exon 1. The stop 
codon is located in exon 4 (5), The mature, secreted form of GH is approximately 190 
amino acids and 22 kDa in size. 
GH is synthesized by somatotropes of the anterior pituitary gland. The regulation 
of GH secretion is complex involving primary regulation and secondary modifers that 
influence both the amount and pattem of GH release. The primary regulators are 
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somatostain and GH releasing hormone (GHRH). GHRH can stimulates the release of 
GH and stimulates the translation and transcription of the growth hormone receptor 
(GHR) mRNA by binding to specific GHRH receptor through a cAMP pathway (6). 
The other regulating factor is somatostatin. It blocks GH secretion by decreasing the 
cellular permeability to Ca:+ or K+(7). 
1.1.2. Actions o f G H 
The metabolic effects of GH can be classified into insulin-like and anti-insulin 
like actions. The insulin-like actions include the stimulation of the glucose transport 
(8), acceleration of glucose metabolism to fatty acids and CO2 (9) and conversion to 
glycogen (10) and the increase of the oxidation of leucine and pyruate by activating 
the a-ketoacid dehydrogenase and pyruvate dehydrogenase at the mitochondrial 
branched chain (11). Insulin-like actions also include antagonism of the lipolytic and 
the glycogenolytic effects of epinephrine (12). The anti-insulin like actions include 
the increased lipolysis (13,14)，decreased glucose transport (15) and increased serum 
nonesterified fatty acids (16). 
The mechanism of these effects of GH on target cells or organs can be classified 
into direct and indirect actions. In the direct action, GH is directly acting on the target 
tissues, for example, the promotion of lipolysis in adipose tissue and the stimulation 
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of glucose and amino acid uptake in muscle. In the indirect action, the effects are 
mediated via insulin-like growth factor - I (IGF-I). GH stimulation of proliferation of 
osteoblasts and myelin formation are examples of the indirect actions ofGH. 
1.1.3. Structure of GH 
The crystal structure of porcine GH was resolved by Abdel-Meguid in 1987 (17). 
It is an elongated molecule with the approximate dimensions of 55A x 35A x 35A. The 
molecule contains four a-helices. Of the 191 amino acids of porcine GH, 54% are 
contained in these four a-helices. These helices run in a fashion of up-up-down-down, 
in contrast to the more usual up-down-up-down fashion. In 1992, de Vos (18) showed 
the major structural feature of the hGH molecule (Fig. 1.1). It also contains the 
four-helical bundles. The N- and C- terminal helices are longer than other two. The 
residues 129 to 184 are responsible for connecting the helices C and D. Two disulfide 
bonds are found on hGH. The first disulfide bond is between Cys 53 and Cys 165. 
The other disulfide bond is located at the C- terminus which is linked to helix D 
between Cys 182 and Cys 189. The core of the four helices in hGH is made up mostly 
ofhydrophobic residues, with the exception ofSer 79 and Asp 169. This hydrophobic 
core structure ensures that the major four helices ofhGH can pack closely together. 
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Fig. 1.1. Ribbon representation ofthe structure of hGH, viewed as perpendicular to 
the four-helix bundle. The letters represent the names of the helices and the arrows 
indicate the directions of the helices (18). 
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1.1.4. The sequence of GH 
A number of GH sequences were reported previously, these sequences include 
primates, mammals, avians, amphibians and fish. The amino acid sequences of GH 
molecule from different species are homologous, ranging from approximately 60% to 
90% in amino acid sequence identity. 
When aligned to optimize amino acid similarity, the four Cys residues were 
found to be conserved among all GHs (19，20). These conserved Cys residues may 
assume an important role in the structural integrity and biological activity of the 
molecules. Under chemical reducing conditions, only the Cys 181/189 disulfide bond 
of bGH could be reduced. This result suggests that the small loop of bGH is more 
exposed than the larger loop. The hGH potency was retained when both of the 
disulfide bonds were split and the sulfur atoms carbamidomethylated (21, 22). 
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1.2. Growth hormone receptor (GHR) 
1.2.1. Introduction to GHR 
To initiate the biological actions of GH, GH binds on the GHR at the plasma 
membrane of target cells. This binding stimulates a series of post-receptor events to 
generate the biological actions of GH. 
The first highly purified and cloned GHR is the rabbit liver GHR (23). After the 
sequence of the rabbit GHR was discovered, further studies revealed that GHR shares 
a structural relationship with prolactin receptor and a large group of other cytokine 
receptors such as interleukin (IL) -2,3,4,6,7, granulocyte-marcophage colony 
stimulating factor (GMCSF) and erythropoietin (EPO) (24, 25). These receptors are 
referred as the hematopoietin receptor superfamily (Fig. 1.2). These receptors have 
several common characteristics. All of them pass through the plasma membrane once, 
each containing an extracellular, a transmembrane, and an intracellular domain. The 
extracellular domain is a large N-linked glycosylated and cysteine rich domain. These 
receptors lack the tryosine kinase domain. However, they can phosphorylate some 
downstream signal transduction proteins. The signal transduction processes utilize the 
associated tyrosine kinase of the Janus kinases (Jak) and members of the signal 
transducers and activators of transcription (Stat). 
GHR is a single transmembrane protein. The open reading frame of human GHR 
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(hGHR) contains 638 amino acid residues. The signal peptide contains 18 amino acid 
residues. The extracellular domain has 246 amino acid residues. The transmembrane 
domain contains 24 amino acid residues and the intracellular domain contains 350 
amino acid residues. GHR is glycosylated with an apparent molecular weight of 








































































































































































































































































































































Chapter 1 Introduction 
1.2.2. Structure of the extracellular domain of GHR 
The crystal structure of the extracellular domain was determined by de Vos in 
1992 (18). Fig. 1.3 shows the structure of the extracellular domain of human GHR. 
The extracellular domain of GHR contains two p-sheets, from residues 1 to 123 and 
from 128 to 238. These two p-sheets are linked by a single polypeptide chain. The 
first P"Sheet contains 3 p-strands and the second p-sheet contains 4 p-strands. The 
arrangement of the p-sheets is shown in Fig. 1.4. Together they form a sandwich of 
two anti-parallel p_sheets. The N- terminal domain of the receptor contains 3 disulfide 
bridges. These disulfide bridges link strand A and B by Cys 38 and Cys 48, link 
strand F and G by Cys 108 and Cys 122，and link the two sheets ofsandwich between 
Cys 83 in strand C' and Cys 94 in strand E. 
The cytokine receptor superfamily contains a conserved WSXWS motif. In GHR 
this WSXWS equivalent sequence is also found, which is YGEFS. This YGEFS motif 
is located on the exterior surface of the complex in the second p-barrel domain distal 
to the hormone-binding region and the receptor dimerization interface. This motif 
serves a structural role in correctly positioning the subdomains ofthe second p-barrel 
domain to maintain correct ligand interaction and receptor signaling through 
dimerization interactions. 
Alanine scanning mutations of the extracellular domain ofhGHR have identified 
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9 out of 33 residues located at the interface with the hGH site 1 that contribute to the 
binding affmity of the hGHR (27, 28). The alanine scanning was also performed to 
study the YGEFS motif. Mutations ofTyr 222 and Ser 226 diminished the binding 
and abolished the signal transduction. However, substitution ofGly 223, Glu 224 and 
Phe 225 in hGHR had no effect (29). 
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Fig. 1.3. Ribbon representation of the extracellular domain ofthe hGHR. Both the N-
and C- terminal domains contains seven P-sheets. Residues involved in hormone 
binding are in blue. Residues in the interface between the two receptors in 
dimerization are in green. TheYGEFS motifis in grey (18). 
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Fig. 1.4. Topology diagram of the p-sheets in GHR. A, B，E belong to one sheet. C，C, 
F and G belong to another sheet. C' is significantly shorter than the other stands (18). 
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1.2.3. The regulation of GHR 
The regulation ofGHR can be classified into long-term and short-term processes. 
In the short term regulation, the hormone-induced receptor dimerization appears to be 
required for the down regulation process (30，31). This causes a decrease of 
dissociability of the GHR at the cell surface (32, 33). The hormone binding triggers 
the ubiquitinylation of the intracellular domain of the receptor which is then processed 
to carry out endocytosis and degradation. The residues 318-380 in the membrane 
proximal of intracellular domain was found to be required for hormone mediated 
internalization (34). Within this sequence, Phe 346 is a critical residue. Alanine 
mutation of this residue abrogated the internalization process. Rapid modulation of 
GHR expression by kinase is not well defined. A low concentration of vanadate, a 
tyrosine phosphatase inhibitor, can sharply decrease the surface GHR in IM-9 
lymphocytes (35). Also cAMP can induce a rapid loss of surface GHR expression in 
rat adipocytes (36). 
In the long-term regulation, the existence of up to seven exon 1 promoters for the 
GHR provides great potential of flexibility in the control of the level of GHR 
expression. Also, the alternate splicing of messages provides further possibilities of 
variations in the expression level and location. For example, the exon lA is expressed 
postnatally and its tissue restriction appears to be a result of liver specific transcription 
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factors acting on the 473 bp segment upstream of the transcription start site (37). 
GH can regulate its own receptor. But the role of GH in regulation is variable. 
The treatment with GH in the hypophysectomized rat's adipocytes shows an 
up-regulation to GHR (38). The exposure of cultured cells to GH results in the 
decreased number of GHR. This is because of species differences, receptor occupancy, 
and requirements for specific patterns ofadministration. 
Other hormones also regulate the GHR level. Estrogen can increase hepatic GHR 
(39). The decreased number of the GHR in rats by streptozotocin-induced diabetes 
can be restored by insulin treatment (40). 
1.2.4. GHR biosynthesis 
GHRs are synthesized in the rough endoplasmic reticulum (RER). Then they are 
transported to the Golgi apparatus where they are post-translationaly modified. Finally, 
the receptors are transported to the plasma membrane. The mechanism of transporting 
GHR is unclear, but presumably within vesicles involving both microfilaments and 
microtubules (41). 
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1.2.5. Tissue distribution of GHR 
GHR is widely expressed in various tissues. These tissues include adipose, heart, 
kidney, liver, fibroblasts, lymphocytes and gonads (42, 43). The highest level of 
expression of GHR is found in liver. For some tissues, the expression of the GHR is 
very low. This may be due to the fact that the receptor is only present in a single cell 
type out of a mixed cell population. Most of the GHR are located on the plasma 
membrane. Intracellular GHR have been found in the cytosol and these might 
represent the newly synthesized GHR or the internalized GHR. . 
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1.3. Signal transduction mechanisms of GHR 
1.3.1. Dimerization of GH and GHR complex 
GH contains two binding sites for GHR, site 1 and site 2 (Fig. 1.5). Site 1 of 
the GH consists of a weak determinant in the beginning of helix 1 and much stronger 
ones in the loop between amino acid residues 54 to 74 and the central portion of helix 
4. Site 2 contains 13 amino acid residues in the N-terminus of helix 1 and residues on 
helix 3. Only about 7 of the 31 contact side chains in site 1 of GH accounts for about 
70% of the binding energy (44). . 
The crystal structure of hGH with its receptor has shown that the complex is 
formed of a homodimer of two receptors and a single molecule of GH (Fig. 1.6) (18). 
Further studies have revealed that both sites of GH bind to the same region of the 
hGHR. A sequential complex appears to form with the receptor binding to site 2, 
followed by interaction between the receptor molecules themselves that maintains the 
dimer complex. At high GH concentration, the GH saturate the receptor through site 1 
interactions and acts as an antagonist to prevent receptor dimerization. This sequential 
dimerization is critical to the signal transduction of GHR and this suggestion is 
strengthened by the hGH mutant G120R. The G120R hGH mutant retained a 
functional site 1 but site 2 is sterically blocked. This GH mutant can bind well to the 
receptors, but inhibits cell proliferation in FDC-P1 cells which is transfected with a 
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GHR. It was speculated that once G120R is bound to its receptor, it cannot dimerize 
to induce the GH signal. Therefore, the dimerization of GHR is the first and necessary 
step in the GHR signal tranduction mechanism (45). 
The affinities of two receptor binding sites on GH are very different. The 
high affinity site 1 has a Kd of about 0.4nM, but it has been demonstrated that the low 
affinity site 2 can be occupied only if the other receptor is already bound. The crystal 
structure has shown that the basis for sequential binding is the extra stabilization 
provided by a 500 h^ contact area between the two receptors. The contact epitope 
between hGH and the first GHBP buries about 1300人2，whereas that for hGH with the 
second GHBP buries only 850Al The second human GHBP binds to the GH-GHBP 
is 1350A .^ Therefore an extra SOOA^hUerface of GH-GHBP complex is involved in 
the second receptor binding. Thus the binding of the second receptor requires prior 
binding of the first GHBP, since its binding site is composed of determinants from site 
2 on hGH and the stem portion of the bound receptor. 
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Fig. 1.5. Ribbon representation for binding of hGH to hGHR. The four a-helices are 
labelled as A, B, C and D. Binding site 1 is located at the BD face of the GH. Binding 
site 2 is located at the AC face ofthe GH (28). 
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^^H Fig. 1.6. Backbone structure of the hGH-(hGHBP)2 complex. The hGH is shown in red The hGHBPs are shown in yellow. (18) Page 17
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1.3.2. The J a k and Stat pathway 
The utilization of the Jak kinases (Jakl, 2, 3，and Tyk2) is a common property 
shared by members of the cytokine receptor superfamily. At the time of discovery 
they were two sequences from a multitude of previously unknown protein tyrosine 
kinase (PTK) related sequences emerging from PCR based screening and thus eaming 
the nick name of just another kinase, Jak. Then the discovery that these proteins 
possess two kinase related domains suggested a more leamed justification of the 
acronym Jak, as Janus Kinases, named after the Roman god Janus who possessed two 
faces (46). This group of non-receptor tyrosine kinases has a molecular weight 
, ranging from 125 to 135 kDa. Jak proteins are unique in containing two kinase 
domains and the C-terminal contains all the motifs associated with protein tyrosine 
kinases. The N-proximal domain contains kinase motif but lacks the Src homology 
(SH2) and SH3 domains. Jak activation requires the dimerization of the intracellular 
domains of one or more receptor chains. Dimerization of receptors is proposed to 
bring Jak into sufficient proximity to allow cross-phosphorylation and activation. 
GH predominantly activates Jak2 in vitro (47) and in vivo (48)，although it can 
also stimulate Jakl to a lesser extent in vitro (49). The Box 1 region in GHR is 
necessary for the binding and activation of Jak2 (50). This proline rich region is 
highly hydrophobic and is located at the intracellular domain. The substitution of all 
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four proline residues in this region abolishes the GH-stimulated Jak2 activation. 
Mutants of GHR lacking the Box 1 region are unable to stimulate cell proliferation or 
the gene expression (51, 52). The deletion ofthe N-terminal domain (residues 2-239) 
impairs GHR signal transduction. This may be due to the fact that this deletion 
removes a site required for Jak2 association with GHR (53, 54). After the Jak2 is 
activated by GHR, the Jak2 can activate several downstream signaling pathways. One 
of them is the Stat protein. 
All members of the cytokine receptor superfamily activate a set of transcription 
factors called Stat (signal transducers and activators oftranscription). The Stat family 
has seven members (1，2, 3, 4, 5a, 5b，and 6). They share 28-40% amino acid 
sequence identity within around 700 amino acids but the C-termini differ widely. GH 
can stimulate tyrosine phosphorylation of Stat 1，3, and 5 (55-63). The ability of GHR 
to transactivate Stat 5 appears to be dependent on the presence of at least one Y 
residue in the C-terminal domain of the GHR (64). Before stimulation, Stat proteins 
are localized in the cytoplasm. Stat proteins contain a SH2 domain between amino 
acids 600 and 700. They can bind to the phosphorylated tyrosine residues. Once Stat 
binds on the phosphorylated tyrosine residues, the Jak kinase phosphorylates them 
and the Stat becomes activated. Activated Stat will form dimer. Then the dimer will 
be translocated into the nucleus. In the nucleus, they can bind to specific sequences in 
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the promoters of genes and regulate gene transcription. The rat hepatic Spi 2.1 and 2.2 
genes contain cis-acting elements in response to the Stat protein (65). 
1.3.3. The ras and other signaling pathways 
A number of cytokine-induced responses are associated with activation of the ras 
pathway. The ras pathway includes tyrosine phosphorylation of Src homolgy chain 
(SHC) and associated proteins, Growth factor receptor-bound protein 2 (Grb2) and 
Son of sevenless (SOS). Both SHC and Grb2 have been postulated to link GHR to 
mitogen-activated protein (MAP) kinase activation. GH treatment inducibly 
phosphorylates SHC, probably via Jak2 (66). Grb2 can stimulate the ras signaling 
pathway and MAP kinase activation by interaction with SOS. Grb2 does not appear to 
bind on the GHR or Jak2, but is linked with SHC. 
Other than the Jak-Stat and the ras signaling pathways, the insulin receptor 
substance (IRS) (67)，protein kinase C (PKC) (68，69) and Ca:+ (70) are also proposed 
to be involved in the GHR signal transduction pathway. Fig. 1.7 summarizes the 
signaling pathways of GHR. 
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Fig. 1.7. The GHR signaling pathways. The dotted lines indicate molecules or 
pathways that have not yet been shown to be involved in GH-dependent signal 
transduction (71). 
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1.4. Project aim 
Although the sequences of GHR were well studied in mammalian and avian 
species, the sequences of GHR in lower vertebrates were still unclear. Therefore, the 
Xenopus laevis (an amphibian species) and goldfish (a teleost species) were used as 
models to study the GHR cDNA sequences in lower vertebrates. Other than GHR, the 
Xenopus laevis GH-A and GH-B were cloned in order to study the difference between 
these two isoforms of GH in lower vertebrates. 
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2.1. Preparation of ribonuclease free reagents and apparatus 
General laboratory glassware was treated by baking at 180°C ovemight. Items 
which were not susceptible for baking were treated with diethyl pyrocarbonate (DEPC, 
0.1% v/v). All solutions were treated with 0.1% DEPC ovemight and then autoclaved at 
120°C for 20 min with 1 ppa. on liquid cycle. 
2.2. Isolation oftotal RNA ‘ 
The total RNA in tissue was isolated using TriPure Isolation Reagent (Roche). 
The following procedure is based on the instruction manual provided by the supplier. 
About 0.1 g of tissue was homogenized at room temperature with 1ml TriPure Isolation 
Reagent. Chloroform (200^il) was added into the homogenized tissue. The mixture was 
shaken vigorously for 10 sec and kept on ice. The mixture was centrifuged at 12,000g for 
10 min at 4°C in a microcentrifuge. The supernatant was saved into a fresh 
microcentrifuge tube immediately. The RNA was precipitated with 500^1 isopropanol. 
The precipitated total RNA was collected by centrifugation at 12,000g for 10 min at 4°C. 
The RNA pellet was washed by 1ml 70% ethanol. Under this condition the RNA can be 
stored at -20°C for 1 year. Before use, the ethanol was removed by centrifugation. The 
total RNA pellet was dried in a DNA Speed Vac (Savant) for 10 min and then dissolved 
in 50^il DEPC water. The yield and purity of RNA was determined by spectrophotometry 
(Section 2.4) and formaldehyde agarose gel electrophoresis (Section 2.8). 
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2.3. Isolation of mRNA 
The following method is based on the PolyATract mRNA Isolation System 
(Promega). Total RNA (0.1-1.0mg) isolated from tissue was dissolved in 500^il RNase-
free water. The RNA was placed in a 65°C heating block for 10 min. After 10 min, 3^1 of 
the biotinylated-oligo(dT) probe and 13 i^l of 20X SSC were added into the mixture. The 
mixture was incubated at room temperature with mixing for 10 min. During the 
incubation, the Streptavidin MagneSphere Paramagnetic Particles (SA-PMPs) were 
washed by 0.5X SSC (0.3ml per wash) 3 times and resuspend in 0.1ml 0.5X SSC. After 
the incubation, the entire contents were added into the tube containing the washed SA-
PMPs and incubate at room temperature for 10 min. The SA-PMP was captured by a 
magnetic stand. The supernatant was carefully removed. Then the RNA captured SA-
PMPs was washed by O.lX SSC (0.3ml per wash) 3 times. Finally, the mRNA was eluted 
by 0.25ml RNase free water. The mRNA was stored at -70°C before use. 
2.4. Spectrophotometric quantification and qualification ofDNA and RNA 
The amount of nucleic acids was determined by spectrophotometry and readings 
were taken at 260nm. A 5\x\ of sample was dissolved into 995^1 water. An OD260 of 1 
was taken to correspond to approximately lO^ig/^il DNA for double-stranded DNA. For 
RNA, a 4^1 of sample was added into 996|il water. Here, an OD260 of 1 was taken to 
correspond to lO^ig/^il RNA. The purity of nucleic acids was determined by the ratio 
between the readings at 260nm and 280nm. Pure preparation of DNA has a OD260/OD280 
value o f l . 6 or above. For pure RNA, the ratio of OD260/OD280 is around 2.0. 
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2.5. First strand cDNA synthesis 
The following procedure is based on the instruction manual provided by the 
supplier. Either total RNA or mRNA was converted into first strand cDNA by 
SuperScript II Reverse Transcriptase from Gibco BRL. Around l-5p-g of total RNA or 
50-500ng of mRNA was mixed with l^il of oligo(dT)12-i8 (500mg/ml) and RNase - free 
water was added to a volume of ll^il. The mixture was heated at 70°C for 10 min and 
was quickly ice chilled. 4^il of5X First Strand Buffer, 2^il O.lM dithiothreitol (DTT), l^il 
of lOmM deoxynucleotide triphosphates (dNTPs) mix and l^il of RNasin were added to 
the solution mixture. The contents were mixed gently and incubated at 42°C for 2 min. 
Then l^il (200units) SuperScript II was added to the reaction mixture and incubated at 
42°C for 1 h. Finally, the reaction was stopped at 70°C for 15 min. The first strand cDNA 
was stored at -20°C until use. 
2.6. Agarose gel electrophoresis ofDNA 
DNA was separated in 1 to 1.5% (w/v) agarose gel with Tris-Acetate acid-EDTA 
(TAE) as buffer. These gels were prepared by dissolving 1 to 1.5% agaorse (w/v) in IX 
TAE buffer and 0.5|ig/ml ethidium bromide. The DNA sample was mixed with an 
appropriate amount of 6X agarose gel loading buffer to give a final concentration of IX 
solution. Then the sample was loaded into the slots of the gel which was placed into the 
electrophoresis tank and covered by IX TAE buffer. A voltage of 100V was applied. 
When the bromophenol blue has migrated for an appropriate distance through the gel, the 
gel was examined under ultraviolet (UV) light. 
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2.7. Formaldehyde agarose gel electrophoresis ofRNA 
Total RNA or mRNA was fractionated on a 1% formaldehyde agarose gel. This 
agarose gel was prepared by mixing 3.5 parts of agarose in water, 1.1 parts of 5X 3-CN-
morpholine) propanesulfonic acid (MOPS) buffer and 1 part of 12.3M formaldehyde 
solution. The gel was pre-run for 5 min at 50V before loading the samples. RNA sample 
(up to 30|ug in a 4.5|il volume) was mixed with 2 i^l 5X formaldehyde gel running buffer, 
3.5^il formaldehyde and lO i^l formamide. The sample was incubated at 65°C for 15 min 
and ice chilled. After that, the sample was mixed with ethidium bromide (0.5^g/ml) and 
loaded into the slots of the gel. A voltage of 40-60V was applied. The electrophoresis 
was stopped when the bromophenol blue has migrated to 2/3 length of the gel. The gel 
was examined under UV light. 
2.8. Vacuum transfer ofDNA to a nylon membrane 
The agarose gel for DNA was prepared as described in Section 2.6. Before the 
transfer the DNA was denaturated in denaturing solution for 15 min two times. The gel 
was rinse by distilled water. Then DNA was neutralized in neutralization solution for 15 
min two times. After these treatments, a nylon membrane was placed on the blotter. Then 
a membrane was carefully placed between the membrane to the agarose gel to prevent 
short cut. A small volume of 20X SSC was added on the top of the agarose. Finally the 
vacuum pump was tumed on to begin the vacuum transfer. The pressure was kept at 50 
mbar for 1.5 to 2 h until the transfer was completed. The DNA on the nylon membrane 
was cross-linked by UV in an UV cross-linker for 4 min. The cross-linked membrane was 
stored at 4°C until use. 
Page 26 
Chapter 2 Materials and Methods 
2.9. Nucleic acids purification by MicroSpin (S-200 HR) columns 
The procedure below was based on the protocol suggested by the supplier 
(Amersham Pharmacia Biotech). The resin in the column was resuspended by vortexing. 
Then the cap of the column was loosened 1/4 tum and the bottom closure was snapped 
off. The column was placed in a 1.5ml screw-cap microcentrifuge tube for support. The 
column was pre-spin at 735g for 1 min. The column was then placed in a new 
microcentrifuge tube and the sample was applied to the top of the resin. The column was 
spun at 735g for 2 min. The purified sample was collected in the microcentrifuge tube. 
2.10. DNA radioactive labeling by nick translation 
-^， 
The DNA probe used in Southern blot and library screening was labeled with P 
by the Nick Translation Kit N500 (Amersham Pharmacia Biotech). This protocol was 
modified from the supplier's suggested method. Around l-5^tg of purified DNA was 
^ ^ •_« 
mixed with lO i^l of nucleotide mix, 5 i^l of a - P-dCTP, 5 i^l of enzyme mix and the final 
volume was adjusted to 50^tl. The mixture was incubated in a 14-15°C water bath for 2 h. 
After the incubation, the radioactive labelled DNA was further purified by a MicroSpin 
column (Section 2.9). The unlabelled DNA was removed. The labelled probe was 
denatured at 95-100°C for 5 min. The labelled DNA fragment was used immediately 
without storage. 
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2.11. Southern blot analysis 
The DNA containing membrane was prepared as described in Section 2.8. Calf 
thymus DNA (200|ul) was denatured at 99°C for 5 min and added into 50ml of 
hybridization solution. The membrane (11cm x 14cm) was pre-hybridized in the 
hybridization solution with calf thymus DNA. The membrane was pre-hybridizated 2 h in 
a 65°C water bath. During pre-hybridization, the radioactive labelled DNA probe was 
prepared by the nick translation labelling method (Section 2.10). The radioactive-labelled 
probe was added to the hybridization solution and mixed gently. Then the membrane was 
incubated with the probe ovemight at 65°C. Finally, the hybridizated membrane was 
washed by different concentrations of SSC with 0.1 % SDS. After washing, the 
membrane was wrapped and the signal was detected by autoradiography (Section 2.12) or 
analysed on a Molecular Imager (BioRad GS505). 
2.12. Autoradiography and molecular imager 
Kodak Bio-Max MR film was used for detecting the hybridization signal of 
library screening and Southem analysis. The films were exposed with the hybridized 
membrane in a Kodak X-Omatic cassette at -70°C. After exposure, the films were 
developed with Kodak X-ray developer for 5 min, fixed with Kodak X-ray fixer for 5 min 
and rinsed with running water for 5 min. The developed film was ready for analysis. 
Other than autoradiography, the radioactive signal can be detected using the 
Molecular Imager (Bio-Rad GS-505). The operation procedure of the Molecular Imager 
System is as follows. The imager scanner is tumed on and allowed to warm up for at least 
15 min. The imaging screen is inserted into the Eraser to erase the background signal for 
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at least 10 min. The radioactive sample is enclosed in a heat-sealable bag and taped it 
onto the Load Dock Exposure Pad. The entire exposure pad was covered with a sheet of 
Screen-Guard film. The Exposure Pad was placed into the Loading Dock. The imager 
screen was inserted into the Loading Dock with, the phosphor side of the imaging screen 
facing down. After the appropriate exposure time (typically 1/10 the exposure time for 
film), the screen was removed from the Loading Dock. The screen cassette was inserted 
into the scanner. The signal was analysed by the Molecular Analyst software. 
2.13. Linearization and dephosphorylation of plasmid DNA 
Plasmid vector (5^g) was digested with 50 units of suitable restriction enzyme(s) 
in a 50^il reaction mixture. Then 5.5^il of 10X Calf Intestinal Phosphatase (CIP) buffer 
and 1 unit of alkaline phosphatase was added and the mixture was incubated at 37�C for 
30 min. One more unit of alkaline phosphatase was added and the incubation was 
continued for another 30 min. The digested vector was purified by QIAGEN nucleotide 
purification kit and finally eluted in 30^il water. These pre-treated vectors were stored at 
-20°C until use. 
2.14. Purification ofDNA from agarose using QIAEX II kit 
The following method was based on the suggested protocol of the supplier 
(Qiagen). The DNA band was excised from the agarose gel with a clean and sharp scalpel. 
3 volume of Buffer QX was added to the gel and the gel was melted at 50°C for 5 min. 
QIAEX II (10|il) was added to the melted gel after vortexing. The mixture was incubated 
at 50°C for 10 min and was vortexed every 2 min. The QIAEX II pellet was saved by 
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centrifugation at 12,000g at room temperature for 30 sec. The pellet was washed by 
500^il PE two times and was air-dried for about 10 min until the pellet becomes white. 
Finally, the DNA was eluted by 20^1 lOmM Tris-Cl. The product was stored at -20°C 
until use. 
2.15. 3，End modification ofPCR amplified DNA 
The 3’ ragged ends of the PCR fragements were modified by the following 
method. The PCR sample was loaded into a TAE agarose gel. After electrophoresis, the 
PCR agarose gel containing the desired DNA was purified by the procedure as described 
in section 2.14. Ten ^1 of 5X Forward Reaction Buffer, 2^il of lOmM dNTPs, l^il of 
O.lM ATP, 10 units of DNA Polymerase I (Promega) and 10 units o fT4 polynucleotide 
kinase (Promega) were added to the purified DNA. Water was added to a final volume of 
lOO i^l and the reaction mixture was incubated at 37°C for 1 h. Then the modified DNA 
was purified by the nucleotide purification kit (Qiagen) or by gel extraction (Section 
2.14). The final product was stored at -20°C until use. 
2.16. Ligation ofDNA fragment to linearized vector 
The following protocol describes the general conditions for the ligation reaction. 
The vector (5ng) and an appropriate amount of foreign DNA (2:1 to 3:1 in DNA to vector 
ratio) was mixed together. Then 10X ligation buffer was added to the reaction mixture to 
a final concentration of IX. One i^l o fT4 DNA ligase (Promega, 3U/^il) was added and 
the mixture was incubated ovemight at 16°C. The product was stored at -20°C before 
transformation. 
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2.17. Preparation of Escherichia coli competent cells 
Appropriate strain of Escherichia coli (E. coli) was streaked directly from frozen 
stock onto the surface of a LB (Luria-Bertani) agar plate and incubated ovemight at 37°C. 
A single colony was transferred to 5ml LB medium and incubated at 37°C for 2 h. Then 
this 5ml LB medium was inoculated into 100ml LB medium. The cells was grown at 
37°C until ODeoo reached 0.4 - 0.5. The culture was chilled on ice for 150 min. The cells 
were harvested by centrifugation at 1000g for 15 min at 4°C. The pellet was resuspensed 
in 37ml RF1 and kept on ice for 15 min. The cells were centrifuged again at 1000g for 15 
min at 4°C. The cell pellet was resuspended by 8ml RF2 and kept on ice for 15 min. The 
competent cell suspension was dispensed into aliquots of 100^1 each and frozen in liquid 
nitrogen. The competent cells were stored at -70°C before use. 
2.18. Transformation 
2.18.1. Bacterial t r ans fo rmat ion by hea t s tock 
An appropriate amount of plasmid DNA or ligation product was added to lOO i^l 
competent cells. The mixture was kept on ice for 30 min. The cells and plasmid was heat-
shocked at 42°C for 45 sec. The mixture was rapidly transferred to an ice bath to chill the 
cells for 2 min. LB medium (0.9 ml) was added to the mixture. The mixture was 
incubated at 37°C for 1 h. After incubation, the cells were harvested by centrifugation 
(12,000g for 1 min in a table-top centrifuge). All the cells, 20^il (20mg/ml) 5-bromo-4-
chloro-3-indolyl-P-D-galactoside (X-gal) and 20^il O.lM isopropylthio-P-D-galactoside 
(IPTG) were mixed and spread onto a LB plate containing the appropriate antibiotic. 
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After the liquid had been absorbed, the plate was inverted and incubated at 37°C 
ovemight. 
2 .18.2. Bacterial t r ans format ion by electroporation 
The cuvette was put into ice before transformation began. The electro-competent 
cells were thawed on ice. The competent cells (100^1) were transferred into the cuvettes. 
Then the appropriate amount of plasmid DNA or ligation product was added into the 
competent cells. The cuvette with the mixture was inserted into the tray of the 
Electroprator 2410 (Eppendorf). The electric pulse was applied at a voltage of 2.5kV. 
After the electric pulse, 1ml of 2X YT or LB was added and mixed gently. The mixture 
was transferred into 1.5ml microcentrifuge tube and incubated at 37°C for about 1 h. 
After incubation, the cells were harvested by centrifugation (12,000g for lmin in a table-
top centrifuge). All the cells, 20^il X-gal (20mg/ml) and 20^il O.lM IPTG were mixed and 
spreaded onto a LB plate containing the appropriate antibiotic. After the liquid had been 
absorbed，the plate was inverted and incubated at 37°C ovemight. 
2.19. Mini preparation of plasmid DNA 
2.19.1 . Using Q u a n t u m Prep Plasmid Miniprep Kit 
This method is based on the protocol suggested by the supplier (Bio-Rad). Within 
this method, all the centrifugation steps were performed at maximum speed (>10,000g) in 
a table-top microcentrifuge. The ovemight culture of plasmid-containing cells was 
collected by centrifugation for 30 sec. All the supematant were removed by aspirating or 
pipetting. The cell pellet was resuspened by 200^il Cell Resuspension Solution. The Cell 
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Lysis Solution (250^1) was added and mixed gently by inverting about 10 times. 
Afterwards, 250^il of the Neutralization Solution were added and gently mixed by 
inverting. The cell debris was removed by centrifugation for 5 min. The cleared lysate 
was saved into a fresh microcentrifuge tubes. The Quantum Prep matrix (200|il) was 
added and mixed by pipetting. The mixture was transferred into a Spin Filter. The matrix 
was trapped in the Spin Filter by centriftigation for 30 sec. Wash Buffer (500|^ 1) was 
added and the mixture was centrifuged for 30 sec. The filter was washed by the same step 
for two times. Finally the plasmid DNA was eluted by 50^il sterile water (with 50°C) and 
stored at -20°C until use. 
2 .19.2 . Using QIAprep Miniprep Kit 
The following method was based on the suggested protocol of the supplier 
(QIAGEN). All centrifugation steps were carried out at maximum speed (>10,000g) in a 
table-top microcentrifuge. Using l-5ml ovemight culture of E.coli in LB medium, the 
cells were collected by centrifugation. The cell pellet was resuspended in 250^il ofBuffer 
P1. Buffer P2 (250^il) was added and was inverted the tube 4-6 times. Buffer N3 (350|il) 
was added to the mixture and then the tubes were inverted immediately for 4-6 times. The 
mixture was centrifuged for 10 min to remove the debris. The supematant was saved and 
applied into the QIAprep spin column. The plasmid was centrifuged for 1 min. The flow-
through was discarded. To wash the column, 0.75ml Buffer PE was added into the spin 
column and centrifuged for 1 minute. The step was repeated twice. Finally, the plasmid 
was eluted by 50^il Buffer EB. The plasmid was stored at -20°C until use. 
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2.20. Maxi preparation of plasmid DNA 
The following method was adapted from the supplier's protocol (QIAfilter 
Plasmid Maxi Preparation Kit of QIAGEN). A single colony from a freshly streaked 
selective plate was picked and inoculated in a starter culture of 5ml LB containing the 
appropriate antibiotic. The culture was incubated ovemight at 37°C. The starter culture 
was diluted into 100ml selective LB medium in a 1/500 ratio. The diluted culture was 
further incubated at 37°C ovemight. The cells were harvested by centrifugation at 6000g 
in a Beckman JA-10 centrifuge for 15 min at 4°C. The LB medium was completely 
removed. The cell pellet was resuspened in 10ml o f P l (Cell Resuspension Solution) by 
pipetting up and down. Then 10 ml of P2 (Cell Lysis Solution) were added and the 
contents mixed 6 times by inversion. The mixture was incubated at room temperature for 
5 min. Fifteen ml of P3 (Neutralization Solution) was added and the contents mixed 
immediately by inversion. The mixture was poured into the QIAfilter Maxi Cartridge 
immediately, and incubated for 10 min at room temperature. During the incubation time, 
10ml of Buffer QBT was added to equilibrate the QIAGEN Tip. After 10 min, the 
plunger was gently inserted into the QIAfilter Maxi Cartridge to filter the cell lysate into 
equilibrated QIAGEN Tip. The cleared lysate was passed through the resin by gravity 
flow. The resin was washed by 30ml Buffer QC twice. Finally, the DNA was eluted in 
15ml Buffer QF. To precipitate DNA, 10.5ml isopropanol was added to eluted DNA. The 
solution was mixed and centrifuged immediately at 15,000g for 30 min at 4°C. The 
supernatant was decanted. The pellet was rinsed by 70% EtOH and centrifuged at 
15,000g for 10 min. The pellet was air dried for 5-10 min. Finally, the product DNA was 
dissolved in 0.5ml distilled water. The DNA was stored at 4°C until use. 
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2.21. PCR sequencing 
PCR sequencing was performed using the ABI Prism dRhodamine Terminator 
Cycle Sequencing Ready Reaction Kit. This protocol was suggested by the supplier (PE 
Applied Biosystems). The double-stranded DNA in 200-500ng (per lkb in size) was used 
as the template of the reactions. Then 3.2 pmole of primer and 8 i^l of Terminator Ready 
Reaction Mix were added into the tube with the template. Distilled water was used to mix 
up the total volume to 20^il. The mixture was mixed well and spun briefly. On a 
GeneAmp PCR System 9600 thermal cycler, the following PCR cycle was carried out. 
Step Procedures 
1 96°C for 10 sec ^ 
50°C for 5 sec >Repeat 25 cycles 
6 0 � C f o r 4 m i n 
2 Hold at 4°C 
3 Spin down the contents of the tube 
In order to remove the unincorporated dyes, Calf Intestine Alkaline Phosphatase 
(CIAP) digestion and ethanol/sodium acetate precipitation were performed. During the 
CIAP digestion, 1 p,l of CIAP was added into the end product of the thermal cycling. The 
mixture was incubated at 37°C for 30 min. The mixture was transferred into a 1.5ml 
microcentrifuge tube. Two i^l of 3M sodium acetate at pH4.6 and 50^il of 95% ethanol 
were added the contents and mixed thoroughly. The tubes were stored at -20°C ovemight 
to precipitate the extension products. The products were recovered by centrifugation at 
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12,000g for 30 min at 4°C. Then the supernatant was aspirated away carefully. The pellet 
of the DNA was rinsed with 250^il of 70% ethanol. The tubes was centrifuged for another 
5 min at 12,000g. Again, the supernatant was discarded carefully. The pellet was dried in 
a vacuum centrifuge for 10-15 min. Before the samples were run on the ABI PRISM 310 
automatic sequencer, the dried pellet was resuspended in 12|il of Template Suppression 
Reagent (TSR) by vortexing for about 1 min. The samples were denatured at 95°C for 2 
min, then chilled on ice. The sample was vortex and spun. The fmal product was placed 
on ice or store at 4°C in dark until ready to be injected into the autosequencer. 
2.22. cDNA library screening 
2.22.1. Prepara t ion of plat ing bacter ia 
A single colony of host cell bacteria was picked from a frozen stock and 
inoculated in 50ml LB medium containing 0.2% maltose and lOmM MgSO4. The cells 
were incubated at 30°C ovemight with vigorous shaking. The cells were collected by 
centrifugation at 2000g for 5 min. The pellet was resuspended by lOmM MgSO4 and 
diluted until O.D.6oo of the cell suspension was around 0.5-1. The host cell was stored at 
4°C for one week. 
2 .22.2 . Plating 
Appropriate amount of phage was mixed with 200^il of plating bacteria. The 
mixture was incubated at 37�C for 15 - 20 min with shaking. During the incubation, 
0.7% LB top agarose was melted in a microwave oven and cooled down to ~42°C in a 
water bath. After incubation, around 3ml (for each 90mm perti dish) of 0.7% LB top 
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agarose was poured with the phage. The mixture was poured on the pre-warmed NZYMC 
plate immediately. The top agarose added plate was placed at room temperature for 15 
min. Then the plate was incubated at 37°C for 5 — 8 h until the plaques covered the plate 
but were not confluent. The plate was stored at 4°C until use. 
2 .22 .3 Lifting 
Before lifting, the plaque containing plate was pre-cooled at 4°C for at least 2 h. 
A nylon membrane was labeled with a pen and placed face down on a cold plaque -
containing LB plate. The membrane was allowed to be in contact for 4 min. The 
orientation was marked with a 18-G needle. The filter was removed from the plate with a 
pair of blunt, flat forceps and was placed on a Whatman 3 MM paper saturated with 
denaturing solution for 4 min. Afterwards, the membrane was placed on neutralization 
solution for 3 min twice. Finally, the membrane was rinsed in 2X SSC and dried in a 
60°C oven. The phage DNA was cross-linked on the membrane in an UV-cross linker 
(FOTODYNA) for 4 min. The cross-linked membrane was stored at 4°C until further use. 
2 .22.4 . In vivo excresion 
The cDNA fragment inside the phages of interest were released into plasmid by in 
vivo excresion. This protocol was suggested by the supplier of the library (Stratagene). 
The plaque from the agar plate was transferred to a microcentrifuge tube containing 
500^il of SM buffer and 20^il of chloroform. The phage particles were released into the 
SM buffer by vortexing. The phages were store at 4�C. The XLl-Blue MRF' and XLOR 
cells were grown in LB medium for ovemight at 30°C. Next day, 0.5ml of the ovemight 
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culture were added into 50ml LB medium. The cells were grown at 37°C for 2-3 h to mid 
log phase (O.D. 6oo = 0.2 - 0.5). The XLl-Blue-MRF' cells were collected by 
centrifugation (1000g) and the cells were resuspended at an O.D. 6oo of 1.0 in lOmM 
MgSO4. Resuspended XLl-Blue MRF' cells (200^il), phage stock (250^il) and the 
ExAssist helper phage (1^1) were mixed in a 15ml conical tube. The mixture was 
incubated at 37°C for 15 min. Then 3 ml ofLB was added and incubated at 37°C for 2 h 
with shaking. After the incubation, the mixture was heated at 70°C for 15 min. The 
mixture was centrifuged at 4000g for 15 min. The supernatant with the excised 
phagemids were saved. 200^il of freshly grown XLOLR cells was added to lOO i^l of the 
phage supernatant. The mixture was incubated at 37°C for 15 min. Then 300|il ofLB was 
added and the mixture was incubated at 37°C for 45 min. Finally, 200^1 of the mixture 
was plated on LBA agar plates and incubated at 37°C for ovemight. 
2.23. Preparation and sterilization of culture medium 
The culture medium of Chinese Hamster Ovary (CH0)-K1 was minimum 
essential medium (MEM) medium and was prepared in the following way. For lL MEM 
medium, 1 package of MEM powder was diluted in 5% less total volume (1000ml) 
distilled water with gentle stirring. Then 0.35g/L of sodium bicarbonate was added into 
the solution. The medium was stirred until the solids were completely dissolved. The pH 
of the medium was adjusted to 0.2-0.3 below the desired final working pH by sodium 
hydroxide or hydrochloric acid. The pH adjusted medium was sterilized by filtration 
through a 0.24fim membrane filter in a culture hood. 
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2.24. Preparation of frozen stock of culture cells 
^ __ 
For each 75mm flask, the cells were grown until 80% confluence. The cells were 
lifted by adding 0.5ml Trysin/EDTA and incubated at 37°C for 5 min. Five ml of culture 
medium were added to stop the trysin reaction. The medium with the cells was 
transferred into a 15ml Falcon tube. The cells were collected by centrifugation at 900rpm 
for 3 min. The cell pellet was resuspended in 2ml of frozen medium (10% DMSO, 50% 
fetal calf serum (FCS), 40% culture medium). One ml aliquots of the all mixture were 
prepared in the 2ml frozen vials kept at -20°C for 2 h. Then the temperature were ftirther 
decreased to -80°C and stored ovemight. Finally, the cell line was stored for long term 
under liquid nitrogen. 
2.25. Cell passage ofCHO-Kl 
The cultured cells were sub-cultured using the following procedure. The cells 
were washed by -lOml phosphate buffered saline (PBS). Then 0.5ml (for a 75mm^ flask) 
Trysin/EDTA was added into the flask and incubated at 37°C for 5 min. Five ml of 
culture medium were added to stop the trysin reaction. Then the cells were transferred 
into a 15ml Falcon tube. The cells were collected by centrifugation at 900rpm for 3 min 
at room temperature. The pellet was resuspended in 5ml culture medium. Appropriate 
amount of the resuspended cells were added into culture flasks with 10ml culture medium. 
The cells were incubated in a CO2 incubator. 
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2.26. Counting of cell 
The cells were collected by Trypsin/EDTA solution and resuspended by culture 
medium as described in Section 2.23. Ten i^l of the resuspended cell were mixed with 
lO i^l of 1% Trypan Blue solution. Ten i^l of the stained cells were filled into the grip of a 
hemocytometer. The cell number of four comers and the central area was counted. The 
concentration of cells was calculated by the following equation: 
(N/5)*2*10^=C 
N= Total number of cells counted 
C = The cell concentration in cells/ml 
2.27. Proliferation assay performed on CH0-K1 cells (MTT method) 
Cells were seeded in a 96-well plate in appropriate numbers. The cells were 
allowed to grow in the culture medium with 10% ofFCS ovemight. Then the cells were 
starved ovemight using medium without FCS before assay. After starvation, different 
doses of hormones dissolved in 200^il of culture medium were added and the cells were 
further incubated for 24 h. The hormones were removed by aspiration. The cells were 
washed by 200^il of lx PBS twice. Fifty |il of3-(4,5-Dimethylthiazol-2-yl)-2,5-dipenyl-
tetrazolium bromide (MTT) solution (5mg/ml) was added into each well. The plate was 
incubated at 37�C in a CO2 incubator. After 2 h, 150^il of DMSO was added and the 
O.D.54o nm was detected on an ELISA plate reader (Bio-Rad). 
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2.28. Luciferase assay 
The Dual-Luciferase Assay System of Promega was used. The following 
procedure was based on the suggested protocol of the supplier. The testing cell line was 
plated on a 24-well culture plate until 50-80% confluence. The promoter containing 
pGL2 vector was transfected into the cell line using lipofectamine reagent (Gibco BRL). 
Details are the same as in Section 2.39. The pRL/CMV was co-transfected into the cell 
line. The ratio of pRL/CMV to pGL vector was 1:4. After 6 h of transfection, 1ml of 
hormones at different concentrations was added and incubated for another 20 h. Then the 
hormones were removed by aspiration. The cells were washed by 1ml PBS. To lyse the 
cells, 50^1 of IX Passive Lysis Buffer was added and incubated at room temperature for 
15 min with shaking. The lysate was collected and used in the detection assay. For each 
sample, 20^il of lysate was mixed with 50^il ofLAR II reaction substrate in a 12 x 75 mm 
tube. Light emission was detected immediately on a Lumat LB 9501 luminometer. 
Afterwards, 50^il of Stop and Go reaction mix were added into the mixture. Again, the 
light emission was detected. 
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2.29. SDS-PAGE preparation 
The following procedure describes the preparation of SDS-PAGE of proteins in a 
15% gel. For other gel concentrations, the 40% acrylamide stock and distilled water were 
adjusted to appropriate ratios. The Bio-Rad Mini-PROTEAN II Cell gel set was used in 
the experiments. Before casting the gel, the apparatus was washed by 70% EtOH and 
dried completely. The spacer was inserted in between one larger and one small glass. The 
glasses with spacers were inserted into the gel stand. To prepare a 15 % separating gel, 
1.15ml of distilled water, 1.25ml Lower Buffer, 2.5ml 40% acrylamide stock and 0.25ml 
10% sodium dodecyl sulfate (SDS) were mixed in a glass tube. Then 75^il of 10% 
ammonium persulfate (APS) and 1.25^il of N,N,N,N — tetramethyl ethylenediamine 
(TEMED) was added into the mixture. The mixture was loaded into the gel set 
immediately in appropriate amount (-4ml). Approximately 0.5ml of isopropanol was 
loaded on the top of the acrylamide gel to remove the bubble. After the separating gel 
was formed. The isopropanol was removed by filter paper. Then a 5% of stacking gel was 
added on the top of the separating gel. The component of the 5% of stacking gel was 
prepared by mixing 1.65ml distilled water, 0.75ml Upper Buffer, 0.5ml 40% acrylamide 
stock, 30^il of 10% SDS, 40^il of 10% APS and 3^il ofTEMED. Before the stacking gel 
formed, the comb was inserted into the gel. After the stacking gel was formed, the comb 
was removed and the wells were washed by water. The gel was ready to use. 
2.30. SDS-PAGE analysis of proteins 
The protein sample was mixed with the 2X Sample Buffer in a ratio of 1:1 (v/v). 
Then the mixture was denatured in boiling water or at 99°C in a thermomixer for 15 min. 
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After denaturation the sample was loaded into the wells of the gel. The gel was run at a 
constant current of 35mA until appropriate distance was reached. Then the gel was 
removed from the gel set and stained in Coomassie Blue Stain solution for 1 h to 
ovemight. The gel was destained in Destaining solution for 1 h. Finally, the gel was 
cleaned by distilled water. The bands were visible and photos were taken. 
2.31. Recombinant protein expression 
The suitable competent cells (lOO^il) were thawed on ice. One i^l of plasmid (~10-
lOOng/^il) was added and mixed gently. A heat shock transformation was preformed 
(Section 2.18.1). The transformed cells was plated out and selected by two antibiotics (for 
competent cells and plasmid). After 37°C ovemight incubation, several different colonies 
were picked by toothpicks and grew in 3ml culture medium with antibiotics. The culture 
was incubated ovemight at 37°C. Next day, the culture medium with antibiotics was 
aliquoted into different tubes. For each tube the ovemight culture in 1:1000 (v/v) was 
added into the medium. The mixture was incubated at 37°C. At different times, of O.D.6oo 
was measured. When the absorbance reached 0.4-1 unit, O.lM IPTG was added in a ratio 
of 1:100 (v/v) to induce protein expression. For the control, no IPTG was added. After 5 
h to ovemight incubation at 37°C. The recombinant protein expressed cells were 
collected by centrifugation (14,000g 1 min for 3ml culture). The pellet was saved and 
resuspended in IX TBS. The protein sample was stored at 4°C until use. 
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2.32. Small scale purification of recombinant proteins 
The following protocol was used in small scale (-3ml culture) purification of 
recombinant proteins in denatured form. This procedure was based on the suggested 
protocol of the supplier (Invitrogen). The recombinant protein-containing E. coli was 
resuspended in 3ml of IX TBS. The cells were lysed by sonication for about 3 min or 
until the solution became clear. The protein was recovered by centrifugation (14,000g, 10 
min). The pellet was saved and 500p,l of Purification Buffer, pH 7.8 were added. The 
pellet was resuspended by vortexing for 15 min. The resin (ProBond Resin) was collected 
by centrifugation (-l,OOOg for 1 min) and the resin was was resuspened by adding 500^1 
distilled water. This washing was repeated twice. The resin was washed again by 
Purification Buffer with pH 7.8 three times. Finally, the resin was collected by 
centrifugation and the lysed sample was loaded into the resin. The mixture was incubated 
at room temperature for 30 min with gently mixing. After the incubation, the resin was 
collected by centrifugation. The superantant was saved for SDS-PAGE. Then the pellet 
was washed by 500^1 Purification Buffer pH 7.8 five times, 500^1 Purification Buffer pH 
6.0 two times and 500^il of Purification Buffer pH 5.0 two times. For each pH buffer, the 
supernatant of the first wash was saved. Finally, the recombinat protein was eluted by 
lOO i^l of Purifiaction Buffer pH 7.8 with 100mM EDTA two times. The product was 
saved and stored at 4°C until use. 
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2.33. Restriction digestion ofDNA 
The following protocol was used in the restriction enzyme digestion with two 
enzymes of the same buffering system. Different amounts of DNA were mixed with 3^il 
of suitable buffer depending on the enzymes being used. Then 1 ^ 1 of each enzyme was 
added and the final volume was made up to 30^il by distilled water. The reaction mix was 
incubated at 37°C for 3 h. For complete digestion, lp,l of each enzyme was added again 
and incubated ovemight at 37°C. The restriction enzyme digested DNA was stored at 
-20°C before use. 
2.34. Purification ofPCR product using QIAquick PCR purification kit 
The following procedure was based on the suggested protocol of the supplier 
(QIAGEN). PCR product was purified from this process to remove the primers, enzymes 
and salt. For 1 volume of the PCR reaction, 5 volumes of Buffer PB were added and 
mixed. The mixture was loaded into the QIAquick spin columns and centrifuged at 
14,000g for 1 min. The flow-through was discarded. The QIAquick spin column was 
centrifuged again for an additional 1 min. Buffer EB (30-50^il) or distilled water was 
added and incubated for 1 min. The PCR product was eluted by centrifugation at 14,000g 
for 1 min. The purified PCR product was stored at 4°C until use. 
2.35. TA cloning ofPCR fragment 
Five i^l of 10X PCR buffer with MgCl2, l^il of dNTPs and 0.5^il of Taq 
polymerase (0.5U/^il) was added to the PCR product. The mixture was incubated at 72°C 
for 15-20 min. The tailed product was purified by QIAqucik PCR purification kit 
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(Section 2.34). The purified DNA was ligated into pGEM-T vector using the method as 
described in Section 2.16. The ligated product was transformed into E.coli. (Section 2.18). 
The colonies were picked for further analysis. 
2.36 Transfection of plasmid into CH0-K1 cells 
Transfection of CH0-K1 was performed using the LipofectAMINE reagent 
(GibcoBRL). The following procedure was based on the suggested protocol of the 
supplier. Around 2.5-5 x 10^  of CH0-K1 cells were seeded into a single well of 6-well 
plates. The cells were grown in the growth medium for 1 day or until 50-80% confluence. 
Solution A (6^ig of plasmid in 600^il of MEM) was mixed with' solution B (36^1 of 
LipofectAMINE reagent in 600^il of MEM) and incubated at room temperature for 30 
min. Then 4.8ml ofMEM was added. The cells were incubated at 37°C with CO2 for 6 h. 
Afterwards, the lipofectAMINE was removed and the growth medium was added. Two 
days after transfection, a stable cell line with stable expression of the cDNA was obtained 
by selection in the presence of 500^1/ml G418 (GibcoBRL) for 3 weeks. 
2.37 Sources ofhormones 
The hGH and hPRL were purchased from Vitro Diagnotics, Inc., USA. The 
recombinant goldfish GH I (gfGH I) and goldfish GH II (gfGH II) were provided from 
Mr. Y.H. Chan, a Ph.D. student in the same laboratory. The coding regions of the gfGH I 
and gfGH II cDNAs were cloned and expressed in the pRSET-A (Invitrogen) expression 
system, purified in XPRESS system (Invitrogen) under denaturating conditions and 
refolded by dialysis against lx TBS pH 9.0. 
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2.38 Buffers and Reagents Gel-loading buffer, DNA 
Sucrose 4g 
Adenosine t r iphospha te (ATP), Bromophenol blue 0.025g 
100mM Xylene cyanol 0.025g 
ATP i20mg Distilled water 10ml 
Distilled water 1.6ml Store at 4°C. 
Adjust pH to 7.0 with lM NaOH. 
Adjust final volume to 2ml. Hybridization buffer 
Store at -20°C in 500ul aliquots. 100x Denhardt's Solution 5ml 
20x SSC 30ml 
Ammonium persulfa te , 10% 10% SDS 5ml 
(w/v) distilled water 10ml 
ammonium persulfate 1 g Freshly prepare on the day to use. 
distilled water mix up to 10 ml 
Store at4°C. Isopropyl-p-D-
thiogalactopyranoside (IPTG), 
Bromophenol blue, 10% (w/v) 100mM 
Bromophenol blue lg IPTG 238mg 
Distilled water mix up to 10ml Sterile water . 10ml 
Store at room temperature. Filter sterilize using 0.22|am filter. 
Store in 1ml aliquots at -20°C. 
Denhard t ' s solution, 100 x 
Polyvinylpyrrolidone (PVP) 10g MOPS, buffer 5x 
Bovine serum albumin (BSA) 10g 3-(N-morpholine)propanesulfonic acid 
Ficoll 400 10g (MOPS) 20.95g 
Distilled water 460ml Sodium acetate 3.4g 
Store at -20�C in 50ml aliquots. Na2EDTA*2H20 1.9g 
Distilled water mix up to lL 
E th id ium bromide (EtBr), Autoclave and store at room 
l O m g / m l temperature. 
Ethidium bromide 0.2g 
Distilled water 19.8ml Phospha te -buf fe red sal ine (PBS) 
Store at room temperature and prevent NaCl 8g 
exposure to light. KC1 0.2g 
Na2HPO4 1.44g 
Ethylenediamine te t raacet ic acid KH2PO4 0.24g 
(EDTA), 0.5M Distilled water 900ml 
Na2EDTA*2H20 93.05g Adjust pH to 7.4 with lM HC1 and add 
Distilled water mix up to 300ml water to a final volume of 1L. 
Adjust the pH to 8.0 with 10M NaOH. Autoclave and store at room 
Adjust the fmal volume to 500ml and temperature, 
autoclave. Store at room temperature. 
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SM buffer 
NaCl 5.8g Tris-Cl, 2M, pH7.4 
MgS04*7H20 2g Tris base 242.2g 
2M Tris-Cl, pH7.4 25ml Distilled water 700ml 
1 % (w/v) gelatin 10ml Adjust the pH by concentrated HC1. 
distilled water mix up to 1L Add water to a final volume of 1L. 
Sterilize by autoclave and store at room Autoclave and store at room 
temperature. temperature. 
X-gal (5-bromo-4-chloro-3-
Sodium acetate , 3M indolyl-p-D-galactoside), 
Sodium acetate*3H20 40.8g 2 0 m g / m l 
Distilled water 80ml X-gal 20mg 
Adjust to desired pH with glacial acetic Dimethylformamide (DMF) 1ml 
acid Store at -20°C in glass container. 
Add water to a final volume of 100ml， 
autoclave and store at room temperature. Xylene cyanol, 10% s u s p e n s i o n 
Xylene cyanol lg 
Sodium dodecyl sul fa te (SDS), Distilled water ‘ mix up to 10ml 
10% (w/V) Store at room temperature. 
SDS 100g 
Distilled water 800ml Dena tu r ing Solut ion 
Warm the solution to 50°C to dissolve. NaCl 87.66g 
Add water to a final volume to lL. NaOH 20g 
Distilled Water mix up to lL 
Sodium hydroxide (NaOH), 10M 
NaOH 40g Neutral ization Solut ion 
Distilled water 100ml NaCl 87.66g 
Store in a plastic container at room Tris Base 
temperature. Distilled Water mix up to lL 
SSC buffer , 20X LB bro th 
NaCl 175.3g Tryptone 10g 
Trisodium citrate*2H20 88.2g Yeast Extract 5g 
Distilled waer 800ml NaCl 5g 
Adjust the pH to 7.0 by 10M NaOH. Distilled Water mix up to lL 
Add water to a fmal volume of lL Sterilize by autoclave. 
Sterilize by autoclave. 
LB Agar 
TAE buffer , 50X Tryptone 10g 
Tris base 242g Yeast Extract 5g 
Sodium acetate»3H20 136.1g NaCl 5g 
Na2EDTA.2H20 19g Agar 15g 
Distilled water 700ml Distilled Water mix up to lL 
Adjust pH to 7.2 with acetic acid. Sterilize by autoclave, cool down and 
Add water to a final volume of lL. POur into culture dish. 
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RF1 Solution Transfer Buffer, IX 
Potassium Acetate 30mM Tris Base 25mM 
CaCl2 lOmM Glycine 192mM 
MnCl2 lOmM Methanol 20% 
Glycerol 15% 
Blocking Solution 
RF2 Solution Skim milk powder 0.5g 
MOPS, pH 6.5 lOmM lXTTBS 10ml 
CaCl2 75mM 
Glycerol 15% 2X Protein Sample Buffer, 8ml 
Adjust to pH 6.5 by KOH. Upper buffer 1ml 
Glycerol 1ml 
30:8 Actylamide Solution, 40% 10% SDS 1ml 
(w/v) 2-ME 0.1ml 
Acrylamide 30g 0.05% Bromophenol blue 0.2ml 
Bis-acrylamide 0.8g Distilled water 4.7ml 
Distilled water mix up to 100ml 
Upper Buffer • 
Tris Base 6g 
Distilled water mix up to 100ml 
Adjust the pH to 6.8 by HC1 
Lower Buffer 
Tris Base 18.15g 
Distilled water mix up to 100ml 
Adjust the pH to 8.8 by HC1. 
Electrode Buffer, 5X 
Tris Base 6g 
Glycine 28.8g 
SDS, 10% 10ml 
Distilled water mix up to 100ml 
Coomassie Blue Sta in 
Coomassie Brilliant Blue 0.05% 
Acetic Acid 10% 
Methanol 40% 
Distilled water 50% 
TTBS, IX 
Tris Base 20mM 
NaCl 0.8% 
Tween 20 0.1% 
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Chapter 3 Cloning, Expression and Tissue 
Distribution of Xenopus laevis GHR 
3.1. Introduction 
The cDNA sequences of the GHR of many mammalian and avian species have 
been determined (24, 72-77). But in amphibian species, a lower vertebrate, the cDNA 
sequence of GHR is still unknown. Therefore, we used Xenopus laevis as a model to 
study the GHR cDNA sequence in amphibian species. 
In the present study, a RT-PCR approach using two degenerate primers was 
adopted. A partial fragment of Xenopus GHR (xGHR) with 755bp in size was obtained 
and subcloned into pBluescript vector. Using cDNA library screening and 5'RACE 
methods, the full-length xGHR cDNA sequence was obtained. The xGHR was found to 
contain 2507bp including a coding region that encodes for 603 amino acid residues. 
The expression level of xGHR in different tissues was studied by semi-
quantitative RT-PCR method. The result suggested that xGHR had the highest expression 
level in liver and kidney. The coding region ofxGHR with 1809bp was amplified by RT_ 
PCR. This xGHR coding region was subcloned into the eurkaryotic expression vector 
pRc/CMV and transfected into a mammalian cell line (CH0-K1). RT-PCR demonstrated 
that the xGHR was successfully transcribed in this cell line. Finally, proliferation assays 
were carried out to characterize the response of xGHR to hGH and human prolactin 
(hPRL). The result suggested that xGHR can respond to hGH and promote the 
mitogenesis ofthe CH0-K1 cells. 
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3.2. Materials and Methods 
3.2.1. Molecular cloning of xGHR cDNA 
3.2.1.1. Animals and tissues 
Xenopus laevis were purchased from Carolina Biological Supply Company, USA. 
The Xenopus laevis used in this project were adults. After the Xenopus laevis were killed, 
different tissues were frozen immediately in liquid nitrogen. All the tissues were stored at 
-70�C until use. 
3.2.1.2. Reverse transcription - polymerase chain reaction (RT-PCR) 
The total RNA ofXenopus liver was prepared using the TriPure Isolation Reagent 
(Section 2.2). Using the PolyAT tract mRNA Isolation System (Section 2.3), the mRNA 
was extracted from the total RNA. The first strand cDNA was synthesized (Section 2.5). 
Oligo d(T)i8 primer was used as the synthesis primer in the reverse transcription reaction. 
The Xenopus liver first strand cDNA was used as the template for PCR 
amplification. Using two degenerate primers T17 and P12, a cDNA fragment was 
amplified. The locations of the primers T17 and P12 are in the intracellular domain of 
GHR (Fig. 3.1). The design of P12 was based on the nucleotide partial sequence of 
another amphibian {Rana) GHR. The sequence ofP12 is 5'-GYA GTG GTA AGG CTT 
TCT GTG GTG A-3, (degeneracy = 2). The other primer, T17, was designed from the 
highly conserved Box 1 region of GHR. The sequence ofT17 is 5'-GTT CAA AAR ATH 
AAR GGN ATH GAY CC-3' (degeneracy = 576). The expected size ofthe PCR product 
is around 800bp. Due to the difference in the degeneracy ofthe primers, 5 i^l (lOpmole/^1) 
ofT17 primer and 2^il ofP12 primer (lOpmole/^1) were used. PCR was carried out at 
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different annealing temperatures. The conditions are described in Table 3.1. Ten ^1 ofthe 
PCR products were analyzed on a 1% agarose gel as described in Section 2.6. The 
remaining PCR products (90^il) were stored at 4°C until use. 
Transmembrane Domain 
ExtracellularDomain \ ^ ^ ^ ^ ^ ^ IntracellularDomain 
T I � + 
I Ml 1 
~ ~ • < ~ 
T17 P12 
Fig. 3.1 The locations of the primers T17 and P12. The relative positions ofT17 and P12 
are shown in relation to bovine GHR. Both T17 and P12 primers are located at the 
intracellular domain of GHR. The expected size ofthe PCR product is around 800bp. 
Cycle: Denaturation Annealing Elongation 
T ^ 94�C，2 min ^ ^^II 
2"' to3lst 94°C, 1 min 44, 48，52，54，56, 58 72�C, 2 min 
and 62°C, 1 min 
32" … - ~^ ^^ ^^  72�C，lOmin 
Table 3.1. The PCR conditions of the xGHR partial fragment. The annealing temperature 
ranged from 44 to 62°C on a Robocycler 9600 Gradient PCR machine. 
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3.2.1.3. Subcloning ofPCR amplified DNA fragment 
The desired DNA fragment was removed from the agarose gel. Then the DNA 
fragment was isolated from agarose by the gene clean method (Section 2.14). The blunt 
end ofthe DNA fragment was created by the 3，modification (Section 2.15). The product 
was ligated into a Sma I cut pBluescript SK+ vector using the steps described in Section 
2.16. After ovemight incubation, the ligation product was transformed into XLl-Blue 
DH5a E. coli cells by heat shock transformation (Section 2.18.1). The transformed 
bacteria were spreaded on a LBA plate. The white colonies on the LBA plate were picked. 
The inserts were checked by PCR. The clones with correct insert size were sub-cultured 
in 3-5ml LBA medium. The plasmids inside the culture cells wefe extracted by Bio-Rad 
mini-preparation kit (Section 2.19.1). The sequences ofthe DNA inserts were determined 
by PCR sequencing (Section 2.21) on an ABI 310 automatic sequencer. 
3.2.1.4. Library screening of xGHR 
After the partial sequence of the xGHR was obtained, a Xenopus liver cDNA 
library (Stratagene) was screened. The detailed information of the library is shown in 
appendix A.1. The methods of the library screening are similar to the protocol described 
in section 2.22 with some modifications. At the beginning, the XLl-Blue MRF' host cells 
were used as the plating bacteria (Section 2.22.1). In the phage titering, a serial dilution 
of the library was prepared. The dilutions were 10'', 10.2，10"\ 10'^ 10'^ 10"^  and \0 ' \ 
The plaque forming unit (pfu) of three suitable dilutions were counted and the average 
was used as the reference to the primary screening. 
In the primary screening, 18.2^1 of the 10'^  diluted library stock was used in each 
plate. Each plate contained -45,000 pfu. A total o f l 8 plates were plated out for screening. 
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The plating process was discussed in Section 2.22.2. After 8 h of incubation at 37°C, all 
the plates were stored at 4°C. The membrane lifting was carried out on the next day 
(Section 2.22.3). A double filter lifting was performed for each plate. Therefore, a total of 
36 membranes was used. 
The probe for the Xenopus liver library screening was prepared by PCR 
amplification. Two gene specific primers, xGHRl and xGHRlR were designed from the 
xGHR partial sequence. The sequences of xGHRl and xGHRlR are: xGHRl (sense) 5'-
ACG AGG GTT CAG ATA CTG ACC G - 3，，and xGHRlR (antisense) 5'- CTA ACC 
AAA GCA TAG AAG TCC ATG - 3，. The PCR conditions were the same as in section 
3.2.1.2. with annealing temperature at 56°C. The PCR product was 350bp in size. This 
product was further purified by gene clean method (Section 2.14). The probe was 
radioactively labelled by the Nick Translation method as described in Section 2.10. The 
un-incorporated radioactive nucleotides were removed by spin column purification 
(Section 2.9). The plaque containing membranes were hybridized (Section 2.11) with the 
radioactive probe ovemight at 65°C. After the incubation, the membranes were washed 
by 2X SSC with 0.1% SDS for 15 min twice at room temperature. Next, they were 
washed by IX and O.lX SSC with 0.1 % SDS at 65°C twice. The radioactive signals on 
the membrane were detected by autoradiography (Section 2.12) with 2-5 days of 
exposure. 
The plaques containing positive signal were picked from the plate and 
resuspended in 500^il of SM buffer. The selected colonies were further screened for two 
more times. All screening procedures used the same probe and conditions as the primary 
screening. In the secondary screening, around 450 pfii per plate were plated out for each 
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colony. In the tertiary screening, only around 150 pfu per plate were plated out for each 
colony. After tertiary screening, the selected colonies were excised into pBluescript 
vector from the Uni-ZAP vector by in vivo excision (Section 2.22.4). 
3.2.1.5. 5，Rapid amplification ofcDNA end (5’ RACE� 
The 5，cDNA end sequence of Xenopus GHR was obtained by 5' RACE methods. 
This method was based on the suggested protocol ofthe 5'RACE Kit ofGibco BRL. The 
total RNA from Xenopus laevies liver was prepared as described in Section 2.2. Using 
this total RNA, the first strand cDNA was synthesized by Superscript II Reverse-
transcriptase (Section 2.5). The gene specific primer xGHR3R (5:- TTG ACA TTC TGA 
GTT TGC CCT A - 3，）was used as the primer in the first strand synthesis. Then the first 
strand cDNA was purified by the QIAGEN PCR purification kit (Section 2.34). All the 
first strand cDNA was treated by oligo dC tailing reaction to add several dCs at the 5’ end 
ofthe cDNA fragment. This dC-tailed cDNA (5^il) was used as the template for the first 
round PCR (using xGHR2R: 5'- TAG TGA TCG TGG CAT GCC ATT ATG -3’ and 
abridged anchor primer (AAP): 5'- GGC CAC GCG TCG ACT AGT ACG GGIIGG GII 
GGG IIG —3, as primers (I = Inosine). Afterwards, a nested PCR using xGHR5-lR (5'-
TAG CAG GCC AGA TAA CGA CAA -3，）and universal amplification primer (UAP) 
(5'-CUA CUA CUA CUA GGC CAC GCG TCG ACT AGT AC -3 ' ) as the primers was 
performed. One i^l of the first round PCR product was used as the template. The final 
product from the nested PCR was subcloned into pUC 18 vector by blunt end ligation. 
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3.2.2. Tissue dis t r ibut ion o fxGHR 
3.2.2.1. Animals and tissues 
Twenty Xenopus laevis including ten males and ten females were purchased from 
Carolina Biological Supply Company. The liver, kidney, muscle, lung, testis and ovary 
were dissected and frozen immediately in liquid nitrogen. The tissues were stored at 
-70°C before use. 
3.2.2.2. RT-PCR and Southem blot 
The tissue distribution of xGHR in Xenopus laevies was studied by RT-PCR 
followed by Southem blot analysis. Xenopus laevies were dissected and the total RNA 
and mRNA were extracted from various tissues. The first strand cDNAs were prepared 
from the poly A+ mRNA. PCR using two gene specific primers, xGHRl and xGHRlR, 
were performed. PCR on a house keeping gene (p_actin) was used as the control. The 
sequences of the p_actin primers were pACT-F: 5'-GAC CAG GCC CAG AGC AAG 
AGA GG-3' and pACT-R: CTG CTT GCT GAT CCA CAT CTG CT-3'. The PCR 
conditions were 2 min at 94�C, then 25 cycles of45 sec 94�C，45 sec at 56�C (60�C for 
P-actin) and finally 2 min at 72�C. The PCR products ofxGHR were analysed on a 1% 
agarose gel and blotted onto a nylon membrane by vacuum transfer (Section 2.8). The 
probe of the Southem blot analysis was the PCR product (from xGHRl and xGHRlR) 
amplified from the subcloned xGHR cDNA clone. The radioactive labeling method was 
the same as in Section 3.2.1.4. The membrane was hybridized with the xGHR probes 
ovemight (Section 2.11). After hybridization, the membrane was washed with 2X SSC 
O.lo/o SDS at room temperature for 15 min twice, then the washing process was repeated 
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using IX and O.lX SSC with 0.1% SDS at 65°C for 15 min twice. The membrane was 
dried and the DNA was crosslinked. The result of the Southern blot was detected and 
analyzed on a Bio-Rad Molecular Imager system (GS-505). 
3.2.3. Eurka iy to ic expression of xGHR a n d funct iona l a s s a y of xGHR 
3.2.3.1. Subcloning ofxGHR into pRc/CMV 
Two gene specific primers (xGHR-ORF-Start: 5'- ATG CGC GGC CGC ATG 
GCT TAC TGG CTA TTC TGG -3’ and xGHR-ORF-Stop: 5'- ATG CGG GCC CTT 
ACT TCA TGA CTT TGT TTA C -3 ' ) were designed flanking the entire coding region 
of xGHR. These primers were designed in such a way that they included the restriction 
enzyme cutting sites of Not I and Apa I. PCR with a proof-reading polymerase, Pfu 
(Promega), was carried out. The PCR product was cloned into pGEM-T vector using TA 
cloning method (Section 2.35) and the sequence was confirmed by DNA sequencing. The 
cloned xGHR coding region was released from the plasmid by restriction enzyme 
digestion (Section 2.33) using Not I and Apa I. The released fragment was purified from 
agarose gel by QIAEX II kit (Section 2.14). The product was ligated with the digest 
pRc/CMV vector and transformed into ElectroMAX DH5a (Gibco BRL) competent cells 
by electroporation (Section 2.18.2). 
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3.2.3.2. Expression ofxGHR in CH0-K1 cell 
CH0-K1 were cultured at 37% with 5% CO2 in MEM medium with 10% FCS, 
100 units/ml penicllin, lOOmg/ml streptomycin. G418 (500^g/ml) was added into the 
culture medium to select the expression vector in the transfected CHO-Kl cell lines. Cell 
lines containing the plasmid pRc/CMV alone (CHO-pRC) and pRc/CMV with xGHR 
(CHO-xGHR) were generated. The expression vectors were transfected into CHO-Kl 
cells using the lipofectamine plus reagent (Section 2.36). The CHO-pRC cells were used 
as a negative control. A stable cell line expressing the xGHR was established by G418 
selection for 3 weeks. The expression of xGHR mRNA in the transfected cells were 
confirmed by RT-PCR. The mRNA ofthe CHO-pRC and CHO-kGHR cells were used to 
synthesize the first strand cDNAs as templates. The primers and PCR conditions were the 
same as in the tissue distribution studies except that 30 cycles were used in this 
amplification. A positive control was performed by amplifying the P-actin cDNA 
fragment. 
3.2.3.3. Proliferation assay 
The MTT assay (Section 2.27) proliferation assay was used to assess the 
biological function of xGHR on the transfected cell lines. 1 x lO^cells per well ofCHO-
pRC or CHO-xGHR cells were seeded into a 96-well plate. Then the cells were starved 
for 16 h in MEM. After starvation, different concentrations ofhGH or hPRL were added 
into each well. For each dose of hGH or hPRL, 5 replicates were performed. The cells 
were incubated with hGH or hPRL for 24 h at 37°C in a CO2 incubator. The hormones 
were removed by aspiration. Fifty i^l ofMTT (5mg/ml) were added and the contents were 
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incubated for 2 h at 37°C in a CO2 incubator. DMSO (150^1) was used to lyse the cells 
and the color developed was read on an ELISA plate reader at 540nm. 
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3.3. Results 
3.3.1. RT -PCR of the part ial f ragment 
The partial sequence of xGHR was amplified from the Xenopus laevis liver first 
strand cDNA using the primers T17 and P12. A PCR band of around 800bp in size was 
obtained (Fig.3.2). The PCR at 52°C annealing temperature produced the strongest band. 
This band was subcloned into pBluescript SK+/Sma I vector by blunt end ligation. After 
sequencing, the partial sequence was found to contain 755bp (excluding the primers). 
This sequence was further analyzed on the NCBI database. In the Blastn (nucleotide 
sequence) search, the nucleotide sequence produced the highest scoring to chicken and 
pigeon GHR. Similar results were obtained on the Blastx (amino acid sequence) search. 
M 62 58 56 54 52 48 44 ——Annealing temperature 
Fig. 3.2 The PCR amplification of xGHR partial fragment. The amplification was 
performed using primers T17 and P12. The PCR conditions were as follows: (1) 
denaturation at 94°C for 2 min, (2) 30 cycles of 94�C 1 min, 44�C to 62�C 1 min, and 
72°C 2 min and (3) extension at 72°C for 2min. The PCR product was around 800bp and 
the product from 52°C was cloned into pBluescript SK+ vector. 
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3.3.2. Library screening of xGHR cDNA libraty 
In order to obtain the full-length cDNA sequence of xGHR, a Xenopus liver 
cDNA library was screened. Based on the partial sequence of xGHR, a homologous 
probe was produced by PCR. A total of 18 x 45,000 = 810,000 pfii were plated out and 
screened. Four positive signals were obtained on both filters. Five other positive signals 
were obtained on the first filter alone (Fig. 3.3). After plague purification by secondary 
and tertiary screenings, only clone 1.16 and 1.6 gave positive signals (Fig. 3.4) Several 
colonies were isolated from clone 1.6 and 1.16. All of them were excised into pBluescript 
phagemid from the Uni-ZAP vector by in vivo excision (Section 2.22.4). The excised 
pBluescript was transformed into DH5a competent cells. The DNA inserts of the 
plasmids were confirmed by PCR screening. The larger clone was 1.16, which contained 
an insert of2008bp. The smaller clone was 1.6, which contained an insert around 1.3kb in 
size. The cDNA insert of 1.16 was later confirmed by sequencing to include the 3’ UTR 
with 324bp and the coding region with 1682bp. However, the 5' UTR and the 5' end 
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3.3.3. 5，Rapid amplification of cDNA End (5'RACE) 
Since the clone 1.16 from the cDNA library screening lacked the 5，end region of 
xGHR, a 5，RACE was performed. The result of the 5，RACE was shown in Fig 3.5. In 
the first round PCR, no band could be observed. In the nested PCR, a band of around 
600bp in size was obtained. This fragment was purified and subcloned into pGEM-T 
vector. The sequence was determined by PCR sequencing. This DNA fragment was 
573bp in size. The sequence contained 371bp of5 ' UTR and the first 201bp ofthe coding 
region of xGHR, including the start codon. 
600bp ~ • ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H 
M - v e 1 2 
Fig. 3.5. The results of 5' RACE of xGHR. Lane 1 is the first round PCR of 5'RACE. 
This PCR used oligo dT tailed first strand cDNA as the template. The primers were 
xGHR2R and AAP. Lane 2 is the second round PCR. The primers were xGHR5-lR and 
UAP. Lane M is 100bp marker. Lane -ve is the negative control ofthe nested PCR. The 
nested PCR product with around 600bp was cloned in pGEM-T and sequenced. 
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3.3.4. The full- length cDNA sequence of xGHR 
Combining the sequences from library screening and 5' RACE, the fiill-length 
cDNA sequence of xGHR was obtained (Fig. 3.6). 5’ RACE contributed 573bp of 
sequence and 2008bp was obtained from library screening, with an overlapping sequence 
of 65bp. The full-length sequence of xGHR cDNA thus contained 2507bp including 
371bp 5'UTR, 1812bp coding region and 324bp 3'UTR (Fig 3.8). In the coding region, 
the 1812bp sequence encodes for 603 amino acid residues. The sequence alignment and 
hydrophobicity prediction were performed using this predicted amino acid sequence of 
xGHR. The amino acid alignment of xGHR with other GHR§ was displayed in Fig. 5.12 
in Chapter 5. 
In the hydrophobicity prediction, the Kyte and Doolittle method (78) was 
employed. The result is shown in Fig. 3.7. Two highly hydrophobic regions were found. 
The first one is located at the beginning of the sequence. The other region is located at the 
middle of the sequence. These two hydrophobic regions probably represent the signal 
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5'ggggagcaaagtcagcgacccttctggcttccccctgatacccagaggcacaaggaqgcgcagaaqgaq -303 
gcgagatagcgcggcgggagctgacaggattgtgtcccgagtagcgcggacagcaggactgtgtgacaqct -232 
c a g a g a g t g c g g g a c t t a c t g a t c a c t t t a c t g c c c c g c t c t g c g a g g a a c c g g c a c c g a c t c t a c c a g a a - 1 6 1 
cttttcattgatcgggctggagacgatacataaatgacagcagcaagcttcggtaacagtgaaccccgcta -90 
cacttctggtcttctggagtagaaattttcaccctatactgtctcctgqcgctctctqtaqaqtccaqaca -19 
actggaggttctagaggt 二 _1 
ATG GCT TAC 9 
M A Y 3 
TCG C p T T C T G G G T T A C T G T G A T C C T C C T C T A C A T A G A T G G T T C C A C A G C G G C C 6 3 
_ W L F W V T V I L L Y I Q G S T A A 2 1 
A C T G A T G T G T C C C T T G G A A A G C C A A G G A T C A T C A A G f i ' G C ^ C G A T C A C C G C A A C A G 1 1 7 T D V S Jj G K P R I I K V^^ R S P Q Q 39 
G A A A C C A T A A C T ( T G ^ T A T T G G A C A A A T G G A G A G T T T C G G A A T T T G T C G T T A T C T 1 7 1 
E T I T V £ y Y W T N G E F R N L S L S 57 
G g C C T G CTA � C p C ^ T A C A ^ A ^ A A G A C T G A G G C C A A C T G G A C A G A T 命 2 2 5 
G L L K L Q Y K K K T E A N W T D lc J 75 
C g A G A T A C T A T A A C T G G G G G A G A A A A C A G C / ^ T A T T T C A G T A A A A C C T A T A ^ 2 7 9 
P E) T I T G G^  E N S Vcy Y F S K T Y T 93 
T g A A T T T G G G T C T C T T A T / f c l N A C C A A A C T T ^ A G T G A A G A T A C T G A A T T T G A T 3 3 3 
S I VJ V S Y \ ^ ^ ^ T K L V S E D T E F D 1 1 1 
G A T T A C p G C \ T T C T C C G T T G ^ G A T A T T G T G G A A C C T G A C C C T C C C A T G G C C C T G 3 8 7 
“ Y V ^ F s V D D I V E P D P P M A L 129 
勢 T g G ^ T G T G T T G _ A T C A G C C T G A C C C G T A T G C G C A T A G A T A T C C A G T T A 4 4 1 
L ^ w T V L N I S L T R M R I D I Q L 147 
A G T T G G G ^ C C A C C G C C C T C A G C A G A T G T T T C A A G T G G G T G G A T A A G C C T G G A A 4 9 5 
S W E P P P S A D V S S G W I S L E 165 
T A T G ^ G T T C A C A T A A A G G A A G C C 网 G A A T C C C A G T G G A C A A T A C T G G A T A A A 5 4 9 
V E V H I K E A [N E S Q W T I L D K 183 
G T G C ^ A C T A ^ T A T T T A C C A G T C T A C G C G C T G A A A A C A G G A A A G G A T T A T T T C 6 0 3 
V u T K Y L P V Y A L K T G K D Y F 201 
G f T A G G G T T C G T T G C A ^ C A A C T T T C T A A T G G A A A A T T T G G A G A A T T C A G T G A C 6 5 7 
A K V R C K Q L S N G K F G E F S D 219 
G T G T T G C A C A ^ C C A C T A T C T A T A T T A C C A G A G C C T G A c " C T T " r c T " G A T " G T C C C G 7 1 1 
V L H I P L S I L P E P D L P D V P_ 237 
T T T C T C C T C T T T C T T A T T A T T G G A T T A T T T G G G A T G C T G C T T G T C T T C A T T T T T 7 6 5 J： L L F L I I G L F G M L L V F I F 255 
A ! T C T A G T T T T C A ^ A A G A A G A G G T T A A A G A T G A T A A T C C T T C C A C C G G T C C C T 8 1 9 
I L V F K K K R L K M I I L If p V p| 273 
G^^C C C A M ^ A T A A P ^ G G G A T T G A T C C T G A T C T T T T G C A G A G A G G A A A A T T G G A C 8 7 3 
IV f *S A 氏 V J,l D P D L L Q R G K L D 291 
G # G G T G G G C T C C A T A T T G G C A T G C C A C G A T C A C T A C A A A C A A C A G C T G T A T A A T 9 2 7 
E V G S I L A C H D H Y K Q Q L Y N 309 
G ^ T G A C C C T T G G G T T G ^ T T T A T T G A G C T C G A T C T T G A T G A C A C A G A T G A G A A A 9 8 1 
D •^^  f W V a V 1 fe! L U L U H T D E K 327 
A ^ T G A G G G T T C A G A T A C T G A C C G A C T T C T T G G A G A G G A A C A T A G A A A G A A C C A T 1 0 3 5 
N E G S D T D R L L G E E H R K N H 345 
GAC TCT GGA CGA GCC AGC TGC TGT GAA CCT 1089 
N C L G V K D D D S G R A S C C E P 363 
G ^ T ATT C C A G ^ A C G G A T T T C A G C A A C A G T G A C A C T T G T G A T G G T A C C T C G G A T 1 1 4 3 
U 丄 P E T D F S N S D T C D G T S D 3 8 1 
T p G G G C ^ A C T C A G A A T G T C A A A G A A A A C G A A G C C G A T C T T T T G T G C C T T G A T 1 1 9 7 
h ^ y T Q N V K E N E A D L L C L D 3 9 9 
G ^ G A ^ T C T A A T A G T G T A T C C C C T A C G A A T G T C A G C G T G C C A A A T A C A G A A G A T 1 2 5 1 
^ K S N S V S P T N V S V P N T E D 4 1 7 
G p A G C C C A A A G C C A G ^ G C G G A G A A A A C T T G T C C G G T A G C T G T G A G T G A G A A T 1 3 0 5 
^ ^ ^ ^ P ii A E K T C P V A V S E N 435 
G g C C G A C A A G C T T G C C A G T C T C A G C C C C G A T A A G C A A G A T G A G A G C A A A G C C A 1 3 5 9 
^ ^ 丄 b L P V S A P I S K M R A K P 4 5 3 
A g C A T G G A C T T C T A T G C T T T G G T T A G C G A C A T A A C T C C T G C A G G A A G A C T T C T C 1 4 1 3 
C � T C T C C A G G A C ^ A G A A T G A A G A A T G A G A A T G A A G A A T G T A A C C A A A C A G T T 1 4 6 7 
L b f t3 Q R M K N E N E E C N Q T V 4 8 9 
� C A G C A C C C A G C A A A C CTT A A T C C A G A C A G C C C T T A C A T T T G T G A A T C T G C T 1 5 2 1 丄 U “ P A N L N P D S P Y I C E S A 507 
� A C A G C T T T T T G T G C T G C A A G C A A G C C C A G G G A T A C C G A A G C C A G T G T G A A G 1 5 7 5 
V 丄 A b C A A S K P R D T E A S V K 525 
C p AAT GTA ATT GAG GAT ACC TAC TTC ACC ACA G|A AGC CTT AAC ATC CCT GAG 1629 
A ^ G A A T C C T T G C T T T G C A G A G A A G G C C T C A A G C T A T G A T A T G C C T G T C T C A G A C 1 6 8 3 
M N P C F A E K A S S Y D M P V S D 561 
W A^C TCT GTC CAT ATC A ^ AAC TCC CCA CAA AAT CTT GTA CTC AAC ACT ACT 1 7 3 7 
^ 丄 b V H I I N S P Q N L V L N T T 5 7 9 
G T G C T A C C A A A C A ^ G A G T T T C T C G C A C C G T G C G G C T A C A T G A C C C C C G A C C A A 1 7 9 1 
V L P N K E F L A P C G Y M T P D Q 597 
GJA AAC A ^ GTC ATG AAG T ^ gccattttttaaattctgtgatagtatttaaaagcatgggctt 1855 
h2f9”Ea，a，cp，a，c，ctgcatatat:gctttttct:tgtggttt:atcttgt:aaagaaaaaaagctt:aa 1926 
gcgtatatatatatctatatattaagtgttaagaagatgccaaaatgcttagcaagagattcatgtatgtc 1997 ，32，^tt，ga”t^pgtg，ctagtt:cct^t^^tat:taattatgt:ggccccattggat^ta^a 2068 
ttcaatgtaatcatggtttacagtggaaaggaag|iM|ctatttttcctaiiaaaaaaaaaaaaa;.;. 3' 2 1 ¾ 
!!'S- ^8. The cDNA sequence of xGHR. The sequence in lower case is the untranslated regions. The letter in bold is the start codon 
rhe letters in circles are the conserved cysteine residues. The sign • stand for the stop codon. The YGEFS motif is underlined by a 
ytted line, Boxl and Box 2 regions are boxed in shadow. The signal peptide is underlined by a single line. The transmembrane 
domain is underlined by a double line. The potential Asn-linked glycosylation sites are boxed. 
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3.3.5. Tissue dis t r ibut ion of xGHR mRNA 
The expression level of xGHR in Xenopus was assessed by RT-PCR followed by 
Southem blot analysis (Fig. 3.9). Six tissues in both male and female animals were 
studied. From the results of Southem blot analysis (Fig. 3.9.A), the relative expression 
levels are shown in Fig. 3.9B and Table 3.2 setting the male liver level as 100%. The 
amplification of P-actin was used to normalize the amount of first strand cDNA in the 
experiment. The highest expression level ofxGHR is in liver (100% for male and 38.2% 
for female). The second high expressing tissue is the testis (30.66%). The kidney (24.2%) 
and the heart (23.06%)also have a high expression level'of GHR in male Xenopus. 
However, xGHR is rarely expressed in muscle (male: 8.42%, female: 7.52%) and lung 
(male: 5.22%, female: 6.02%). In general, male expressed more xGHR than female in all 
of the tissues studied. 
Tissue Relative expression level 
Male Liver 1 ^ 
Male Kidney 24.2 
Male Heart 23.06 
Male Muscle 8^42 
Male Lung 5!¾ 
Testis 30.66 
Female Liver 3 ^ 
Female kidney 17.56 
Female Heart 14.78 
Female Muscle 7 ^ 
Female Lung 6.02 
Ovary 14.71 
Table 3.2. The relative expression level of xGHR in Xenopus laevis. (Male liver 
expression level set as 100%) 
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Fig. 3.9. Tissue distribution of xGHR in Xenopus laevis. Panel A shows the Southern 
blotting of xGHR and P-actin (Lane 1: Male Uver, Lane 2: male kidney. Lane 3: male 
heart，Lane 4: male muscle. Lane 5: male lung. Lane 6: testis. Lane 7: female Uver, Lane 
8: female kidney. Lane 9: female heart. Lane 10: female muscle. Lane 11: female lung 
and Lane 12: ovary.) The rehtive expression levels are shown in Panel B. 
Page 70 
Chapter 3 Cloning, Expression and 
Tissue Distribution of xGHR 
3.3.6. Funct iona l a s say o fxGHR in CH0-K1 cells 
A stable cell line expressing the xGHR was prepared to study the biological function 
of xGHR. The full-length coding region of xGHR was amplificated by PCR. Two gene 
specific primers (xGHR-ORF-Start and xGHR-ORF-Stop) were designed covering the 
start and stop regions of the Xenopus GHR cDNA with cloning sites engineered at their 
3，ends to aid the subsequent subcloning process. The PCR was performed by a proof-
reading polymerase, Pfu (Promega). The PCR product of-1.8kb in size (Fig. 3.10) was 
cloned into p-GEM-T and pRc/CMV vectors. 
The expression of xGHR in transfected cell was confirmed by RT-PCR. The result 
of the PCR is shown in Fig. 3.11A. The p_actin amplified in both the CHO-xGHR and 
CHO-pRC cells was used as the positive control of the RT-PCR. The 355bp band only 
appeared in CHO-xGHR cells using xGHR gene specific primers. This suggested that the 
mRNA of xGHR was only found in the CHO-xGHR cells and not in the CHO-pRC cells. 
The proliferation stimulation action of GH on xGHR was studied. Both hGH and hPRL 
were used to induce the proliferation of CHO-xGHR and CHO-pRC cells. Hormone 
concentrations up to 800ng/ml were added to the cell lines. The results are shown in Fig. 
3.11B. The CHO-xGHR cells were induced by hGH only and have a peak value at 
200ng/ml of hGH with 158% increase in proliferation. This stimulation was maintained 
at a high value at 400ng/ml and 600ng/ml GH. The proliferation ofCHO-xGHR dropped 
to 123% when 800mg/ml hGH was added. The CHO-xGHR cells did not respond to 
hPRL, indicating the specificity of the receptor-ligand interaction. The CHO-pRC did not 
respond effect to hGH and hPRL in the proliferation assay. 
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2039bp ^ ^ ^ ^ ^ ^ ^ 1 —•— 
^ ^ ^ 
M 1 
Fig. 3.10 The PCR-amplified MUQn%ihXenopus GHR. Lane M is the lkb marker. Lane 
1 is the PCR product of the xGHR full length coding region with 1812bp in size. 
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Fig. 3.11. The functional assay of xGHR. Panel A shows the RT-PCR of xGHR 
transfected cell lines. Lane M: 100bp marker; Lane 1 CHO-pRC first strand cDNA with 
xGHR gene specific primers; Lane 2: CHO-xGHR first strand with xGHR gene specific 
primers; Lane 3: negative control of xGHR PCR; Lane 4: p_Actin PCR of CHO-pRC; 
Lane 5: CHO-xGHR p_Actin PCR and Lane 6 negative control of p-Actin PCR. B. Two 
different cell lines (CHO-xGHR and CHO-pRC) and two different hormones (hGH and 
hPRL) were tested in the proliferation assay. The dosages used were Ong/ml, lOOng/ml, 
200ng/ml, 400ng/ml, 600ng/ml and 800ng/ml pSf=5). ’ ， 
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3.4. Discussion 
In the present study, the full-length xGHR was obtained. RT-PCR amplified a 
partial sequence of xGHR with 755bp. This fragment resides within the intracellular 
domain and this region is highly conserved in all species. In the Blast search, this 
sequence shows the highest score to chicken and pigeon GHR. This fragment was used as 
the probe in the cDNA library screening with an objective to obtain the ftill-length cDNA 
sequence. Since the mRNA of GHR was rare, only two xGHR clones, 1.6 and 1.16, were 
found after 810,000 pfu were screened. However, these clones still lacked the 5，end 
sequence. Therefore, a 5，RACE method was employed to obtain the 5’ cDNA end 
sequence. RACE was a highly sensitive method to amplify the unknown cDNA 
sequences from a known fragment by PCR. The disadvantage of this method is the ease 
to amplify some non-specific products. In this project, three gene specific primers were 
used to increase the specificity of the PCR and first strand synthesis. Finally, a PCR 
product with 573bp in size was obtained. This sequence included the 5' UTR and the 5’ 
end of the coding region. The result from library screening and 5’ RACE had an 
overlapping sequence of 65bp. The sequences from the two methods were identical in 
this region. Also the amplification of the full-length of xGHR coding region (Fig. 3.10) 
proved that the sequences of 5，RACE and library screening can be amplified from a 
single PCR. Therefore, the sequences from two methods must come from the same 
mRNA sequence of xGHR. Combining the results from both methods, a 2507bp of the 
xGHR full-length cDNA sequence was obtained, including the 5, UTR, coding region 
and 3'UTR. The coding region contain 1812bp which are translated into 603 amino acid 
residues. 
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The amino acid sequence of xGHR was used to perform a hydrophobicity prediction 
(Fig. 3.7). In this prediction, two highly hydrophobic regions were observed. The first 
one is the signal peptide which is located at the beginning ofthe sequence. The other one 
is the transmembrane domain and is located at the middle of xGHR. This prediction 
suggested that this amino acid sequence encodes a signal transmembrane protein. 
The predicted amino acid sequence of xGHR allowed us to compare the difference 
between amphibian GHR and other GHRs. The amino acid alignment is shown in Fig. 
5.12. From the alignment, several conserved regions are found in xGHR. 
In the extracellular domain, the first conserved feature is the conserved cysteine 
residues. These conserved cysteine residues form three disulfide bond linkage at the N-
terminal of the receptor. Another conserved feature is the YGEFS motif. When compared 
to other members of the cytokine receptor superfamily, the WSXWS equivalent sequence 
is found in GHR, which is YGEFS. This YGEFS sequence is located on the exterior 
surface of the complex in the second p-barrel domain distal to hormone-binding region 
and the receptor dimerization interface. This WS equivalent segment serves a structural 
role in correctly positioning the subdomains of the second P-barrel domain to maintain 
correct ligand interaction and receptor signaling through dimerization interactions (18). 
There are three conserved potential Asn-linked glycosylation sites found in xGHR. Also 
another not conserved potential Asn-linked glycosylation sites is found near the N-
terminal of the receptor. These potential glycoslation site may affect the binding affinity 
and the receptor internalization ofGHR (79). 
In the intracellular domain, the conserved regions are the Box 1 and Box 2 regions, 
and the conserved tyrosine residues. The Box 1 region is located near the transmembrane 
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domain of the receptor. This region was proposed as the binding site of the Jak2 protein 
(50). Jak2 is a tyrosine kinase. It is the first protein responsive to the GHR stimulation in 
the Jak-Stat pathway. This Box 1 region also responds to the MAP kinase 
phosphorylation (66), Spi induction (80) and IRS phosphorylation (67). The other 
conserved region is the Box 2 region. This region is responsible for cell proliferation, 
lipogenesis and proteins synthesis (13，14，52, 81). In the intracellular domain, there are 
eight conserved tyrosine residues. These tyrosine resides may be phosphorylated after 
GH binding and dimerization (82). These conserved tyrosine residues have different 
functions, including phosphorylation of intracellular proteins and maximal Stat activation, 
transcriptional signaling and proposed Stat 5 binding sites (64，83-84). 
From the results of tissue distribution, most of the tissues express GHR in Xenopus. 
This indicates the diversified functions of GH in Xenopus. The highest expression level 
of GHR is in Xenopus liver, indicating the role of GH in Xenopus. This suggests that 
xGH acts on the xGHR in the liver to stimulate the production of insulin-like growth 
factor (IGFs). IGFs are mediators of the GH actions (85). Therefore, the indirect actions 
of GH may have a similar mechanism as in mammals. For kidney, the GH action on the 
osmoregulation is important in fish. However, in the case of amphibian, this function is 
not clear. The relative high expression level of xGHR in kidney indicates that GH may 
also affect the kidney function, a role which may be related to osmoregulation (86-87). 
But it is necessary to have further studies to determine the actual function of GH on 
kidney and the functional change of xGHR in osmoregulation during the 
metamorphoresis. 
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The proliferation assay further confirmed that the cDNA sequence we obtained is 
the receptor specific for GH. Another structural similar protein, PRL, was used in the 
assay. But it failed to stimulate the cell growth in CHO-xGHR cell even when a high 
dosage was used. This shows that the expressed xGHR could not cross-react with PRL. 
When the hGH dosage is increased to 800ng/ml, the increases in proliferation of CHO-
xGHR dropped. Since dimerization of GHR is necessary for signal transduction for GH 
actions, a high concentration of GH will cause saturation of GHR to prevent receptor 
dimerization (88). Therefore, the decrease of the proliferation of CHO-xGHR may be due 
to the saturation ofthe xGHR by GH. 
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Chapter 4 Cloning and Expression of Xenopus 
laevis Growth Hormone A and B 
4.1. Introduction 
At 1985, the partial sequence of Xenopus growth hormone isoforms, A (xGH-A) 
and B (xGH-B), were obtained (89). The amino acid sequence homology between 
these two hormones is only 75%. This low homology may be due to the functional 
difference of the two isoforms of the same hormone. However, the full sequences 
have not been completed in the previous work. Therefore, the present study attempts 
to obtain the ftill-length cDNA sequences ofboth xGH-A and xGH-B. From PCR, the 
partial cDNA fragments of xGH-A and xGH-B were amplified. These cDNA 
fragments were used in cDNA library screening in order to obtain the ftill-length 
sequences of xGHs. However, only the xGH-A cDNA could be obtained from the 
cDNA library screening. This clone contained 947bp including 645bp of coding 
region. The cDNA sequence of xGH-B was obtained by RACE methods. The xGH-B 
cDNA sequence contained 937bp including 627bp of the coding region. The mature 
protein sequences of xGH-A and xGH-B were amplified by high fidelity enzyme and 
subcloned into the prokaryotic expression vector (pQE). Both proteins were expressed 
in M15 E. coli cells. The expressed xGH-A and xGH-B were further purified by 
ProBond Resin. 
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4.2. Materials and Methods 
4.2.1. PCR amplification of xGH-A and xGH-B partial fragments 
Based on the partial cDNA sequences of xGH-A and xGH-B reported previously, 
two pairs of gene specific primers were designed. The sequences of the primers are 
shown in Table 4.1. A Xenopus laevis pituitary cDNA library was used as the 
template in the PCR. This library was kindly provided by Dr. G.J. Marten at the 
University of Nijmegen, the Netherlands. In each PCR, 2 i^l of the library was added. 
The PCR conditions are shown in Table 4.1. The amplified fragments were subcloned 
into pGEM-T vector by TA cloning (Section 2.38). 
Primers Sequence 
XGHA-F 5’ - ATC CGA CAG ACA AAG ACA ACA CTC A - 3’ 
XGHA-R 5’ - TTC TAC AAA GCG CCG GCA CTT CAT G - 3, 
XGHB-FS 5, - ACT CCT TTA TGA GAA CGC CT -3， ~~ 
XGHB-R 5，- TGT TCT GGT AGG TCA GGG GAT ATG G - 3， 
Cycle: Denaturation Annealing Extension 
"T^ 94�C’ 2 min ^ ^ 
2"'to31^' 94°C, 1 min 58°C, 1 min 72�C，2 min 
i’nd “ 
32 …― …— 72°C，10min 
Table 4.1. The primer sequences and PCR conditions for xGH-A and xGH-B partial 
fragment amplification. xGHA-F and xGHB-FS were sense primers. xGHA-R and 
xGHB-R were anti-sense primers. 
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4.2.2. cDNA libraty screening of xGH-A and xGH-B 
The Xenopus pituitary cDNA library was screened in order to obtain the 
full-length cDNA sequences for xGH-A and xGH-B. The cloned partial fragments of 
xGH-A and xGH-B were used as probes in the library screening. Ten plates with 
45,000 pfu each were plated out in the primary screening. A total of 10 x 45,000 = 
450,000 pfu were screened. The probes were radioactively labelled by the nick 
translation method (Section 2.10). The screening procedures were the same as 
described in Section 2.22. All the membranes were finally washed in O.lx SSC with 
O.lo/o SDS at 65°C for 15 min. The plaques with positive signals were picked and 
resuspended in 500 i^l SM buffer. The identity of the clones were confirmed by PCR 
using gene specific primers. The positive clones were further selected by secondary 
and tertiary screening. After tertiary screening, the clones were excised into 
pBluescript by in vivo excision (Section 2.22.4). The sequence was determined by 
PCR sequencing. 
4.2.3. Rapid amplification of cDNA ends of xGH-B 
4.2.3.1.3' RACE 
Total RNA was purified from Xenopus pituitary. This total RNA was used as the 
template for first strand cDNA synthesis (Section 2.5) using oligo dT (12-18mer) as 
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the synthesis pimer. Using this first strand cDNA (l^il) as template, a nested PCR was 
performed. In the first round PCR, xGHB-FS and RACE-T (5' - CCG AAT TCT 
CGA GAT CGA TTT TTT TTT TTT TTT TT -3，) were used as primers. In the 
second round PCR, xGHB-FS and RACE-3A (5' - CCG AAT TCT CGA GAT 
CGA — 3') were used as primers with 5 i^l of the first round PCR products were the 
template. The conditions of the PCR are shown in Table 4.2. The discrete bands in the 
nested PCR were purified from agarose gel and subcloned into pGEM-T vector by TA 
cloning (Section 2.38). The sequences were determined by PCR sequencing. 
Cycle: Denaturation Annealing Extension 
~i 94�C’ 2 min ^ ^ 
2 to 36 94°C, 1 min 52°C (firstround PCR) 72�C，3 min 
55°C (nested PCR), 1 min 
37 … - "^ ^^ ^^  72�C, lOmin 
Table 4.2. The PCR conditions of the xGH-B 3'RACE. Different annealing 
temperatures are used in first round and nested PCR to optimized the results. All the 
PCR were performed on the Pekin Elmer Gene Amp 9600 PCR machine. 
4.2.3.2. 5, RACE 
The pituitary first strand cDNA synthesized in Section 4.2.3.1 was also used in 5' 
RACE. 10|il ofthe first strand was purified by PCR purification kit (Section 2.39). 
Ten |il of the purified first stand cDNA was mixed with 5ul 5x tailing buffer, 2.5^1 
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2mM dCTP and 6.5^1 ofDEPC water. The mixture was incubated at 94�C for 3 min, 
and then ice chilled for 1 min. One i^l ofTdT (terminal deoxynucleotidyl transferase) 
was added and incubated at 37°C for 10 min. After the incubation, the TdT was 
inactivated by heating at 65°C for 10 min. 
The tailed cDNA (5^il) obtained above was amplified directly by PCR. 2|il of 
xGHB-R (lOpmole) and 2 i^l of Abridged Anchor Primer (lO^iM) were the primers. 
The PCR conditions were the same as the 3’ RACE. AAP and xGHB-R were the 
primers used. After the first round PCR, l^il of the PCR product was used as the 
template for the nested PCR. XGHB-R and UAP were the primers used. The 
conditions were similar to the first round PCR, except that the annealing temperature 
was changed to 55°C. The discrete bands from the nested PCR were purified and 
subcloned into pGEM-T vector. The sequences were determined by PCR sequencing 
(Section 2.21). 
Page 82 
Chapter 4 Cloning and Expression 
Of xGH-A and xGH-B 
1 . mRNA 
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3'RACE^ ^ '^RACE 
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C=：>- >AAA_.AAAn 
TTL.TTT CC..CC •TTT…TTT 
V (I 
3 . 6 . 
i ^ ~ M ^ - ^ " ^^G1...G1^ 
上丄…丄上丄 ^ M _ CC...CC TTT...TTT 
RACE-T <:Z3 S B xGHB-R 
V (> 
4. 7 xGHB-FS • 
C=P 1¾. 
^ ^ : . ^ » _ " ^ G L G I -
^ g 
RACE-3A � xGHB-R 
Fig. 4.1. The 5’ RACE and 3’ RACE methods ofxGH-B. 1. First strand synthesis 
using oligo dT primer. 2-4, 3'RACE of xGHB. 2 and 3 the first round PCR using 
xGHB-FS and RACE-T as the primers. 4，The second round PCR using xGHB-FS 
and RACE-3A as the primers. 5-6, 5，RACE ofxGH-B. 5. Oligo dCTP tailing ofthe 
first strand. 6. The first round PCR using AAP and xGHB-R as the primers. 7. The 
second round PCR using UAP and xGHB-R as the primers. 
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4.2.4. Expression of xGH-A and xGH-B 
4.2.4.1. Construction of the expression vector 
The sequences encoding the mature proteins (excluding the signal peptides) were 
amplified by PCR using High Fidelity Enzyme System (Roche). The primers were 
xGHA-Start-MP (5'- ATG CGG ATC CTT CCC ATC GGT GCC TC - 3,)，xGHA- RQ 
(5'- ATG CAA GCT TTT AAA TGG TGC AGT TGC TTT- 3'), xGHB- Start- MP 
(5'-ATG CGG ATC CTT CCC AAT GTG CCT C- 3’）and xGHB- RQ (5,- ATG CAA 
GCT TTT AAA TTA CAC ACT TGC - 3’). All ofthe primers included the restriction 
enzyme sites Hind III (in xGHA-Start-MP and xGHB-Start-MP) and BamW I (in 
xGHA-RQ and xGH-B-RQ). The amplified fragments were purified by the gene clean 
method (Section 2.14). Sticky ends were created by enzyme cutting using BamH I and 
Hind III (Section 2.36). The vector pQE was also digested by the same restriction 
enzymes. The digested products were purified by the gene clean method. The xGH-A 
and xGH-B cDNA fragments were ligated with the pQE vector (Section 2.16). The 
ligation products were transformed into DH5a cell. The plasmids were confirmed by 
sequencing. The pQE vector contain the xGH-A and xGH-B inserts were prepared in 
a large scale MAXI preparation (Section 2.20) and subsequently used in the protein 
expression of xGH-A and xGH-B. 
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4.2.4.2. Protein expression of xGH-A and xGH-B 
The xGH-containing pQE plasmid (lfil from the Maxi preparation) was 
transformed into M13 E. coli cells by heat shock transformation (section 2.18.2). The 
cells were selected on LB plate with ampicillin (lO^g/ml) and kanamycin (5^g/ml) 
(LBAK). Single colonies were picked and each inoculated in 3ml LBAK medium. 
After ovemight incubation at 37°C, the culture was added into LBAK medium at a 
ratio in 1:500 (v/v), and incubated at 37�C until O.D.6oo reach 0.4 ~ 1.0. Then 1 ： 500 
of O.lM IPTG was added to induce the expression. The cells were collected by 
centriftigation and resuspended in lx TBS. The cells (lO^il) were analysed on a 15% 
SDS-PAGE. The remaining cells were stored at 4°C until use. 
4.2.5. Purification of recombinant xGH-A and xGH-B 
A small scale purification of the recombinant hormones was performed using the 
Express Purification System of Invitrogen. The following protocol was adopted in a 
small scale (-3ml culture) purification of recombinant proteins in denatured form with 
a poly-His peptide. This procedure was based on the suggested protocol of the 
supplier. The xGH-containing vector transformed E. coli was resuspended in 3ml of 
IX TBS. The cells were lysed by sonication until the solution become clear. The 
protein was recovered by centrifugation (14,000g, 10 min). The pellet was saved and 
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500 i^l ofPurification Buffer, pH 7.8 was added. The pellet was resuspended by vortex 
for 15 min. The resin (ProBond Resin) was collected by centrifugation (-l,OOOg for 1 
min) and the resin was resuspened by 500 i^l of distilled water. This washing was 
repeated 2 more times. The resin was washed again by Purification Buffer with pH 
7.8 for 3 times. Finally, the resin was collected by centrifugation and the lysed sample 
was loaded into the resin. The mixture was incubation at room temperature for 30 min 
with gentle mixing. After the incubation, the resin was collected by centrifugation. 
The supernatant was saved for SDS-PAGE. Then the pelfet was washed by 500^1 
Purification Buffer pH 7.8 for 5 times, 500 i^l Purification Buffer, pH 6.0 for 2 times 
and 500 i^l of Purification Buffer pH 5.0 for 2 times. For each buffer change, the 
supernatant of the first wash was saved. Finally, the recombinant protein was eluted 
by 100|il of Purification Buffer pH 7.8 with 100mM EDTA for 2 times. The product 
was saved and store at 4°C until use. 
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4.3. Results 
4.3.1. PCR of xGH-A and xGH-B partial fragments 
By PCR using the gene specific primers of Xenopus GHs, the partial fragments 
of xGH-A and xGH-B were obtained from the Xenopus pituitary cDNA library (Fig. 
4.2). In the case ofxGH-A, a discrete band with around 450 bp in size was amplified. 
Another discrete band with around 200bp in size was amplified for xGH-B. Both 
fragments were sucessfully ligated into pGEM-T vector and transformed into DH5a E. 
coli. cell by heat stock transformation. Then, the sequertces of these inserts were 
determined by PCR sequencing. These two sequences were identical to the reported 
Xenopus GH partial sequences. 
4.3.2. Libraty screening of xGH-A 
A cDNA library screening was performed with a view of obtaining the 
full-length cDNA sequences of xGH-A and xGH-B. A Xenopus laevis pituitary cDNA 
library in lambda ZAP was used. The partial fragments of xGH-A and xGH-B were 
used as probes. A primary screening was performed on 450,000 pfu. After secondary 
and tertiary screening, two positive signals, namely 9B13 and 10A113 (Fig. 4.3), were 
picked and resuspended in 500^1 of SM buffer. Then the clones were excised into 
pBluescript by in vivo excision. After transformation and sequencing, both positive 
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clones were found to contain the insert for xGH-A. None ofthe positive clones in the 
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4.3.3. 5' RACE and 3' RACE of xGH-B 
By PCR in section 4.3.1, a partial fragment of xGH-B was obtained. However, 
cDNA library screening of a Xenopus pituitary cDNA library did not give any xGH-B 
clone. Therefore, the searching of the sequence was completed by a combination of5' 
RACE and 3'RACE. Fig. 4.4 shows the results ofxGH-B 5'RACE and 3'RACE. 
In the first round PCR of 5, RACE, two bands were observed. The larger band 
was around 750 - 800bp in size, the smaller one was around 500bp in size. In the 
nested PCR the product sizes were similar to the first round PCR, around -750bp and 
~500bp. In the case of3 ' RACE, a major band of around 450bp in size was observed 
in the first round PCR. In the nested PCR, two bands were observed. The larger band 
was around 750bp in size, the smaller band was 450bp in size. All of the bands were 
purified from agarose gel and subcloned into pGEM-T vector. The sequences were 
determined by PCR sequencing. 
After sequencing, the 750bp band in 5，RACE and the 450bp band in 3，RACE 
were found to contain the xGH-B cDNA sequence. The exact size of the 5'RACE 
nested PCR product was 738bp. The exact size of the 3'RACE was 502bp. In 
conclusion, a ftill-length sequence for xGH-B containing 60bp of 5'UTR, 627bp of 








































































































































































































































































































































































Chapter 4 Cloning and Expression 
Of xGH-A and xGH-B 
4.3.4. Sequence analysis of xGH-A and xGH-B 
In the library screening, the xGH-A cDNA sequence was obtained (Fig.4.5). This 
cDNA sequence contains a total of 945bp in size, with a 5'UTR of51bp, a coding 
region of 645bp, and a 3'UTR of249 bp. 
Combining the results of 5’ RACE and 3’ RACE, the xGH-B cDNA sequence 
was obtained (Fig. 4.6). The xGH-B cDNA sequence includes a 5’ UTR with 60bp, a 
627bp coding region and a 3'UTR with 248bp. The xGH-B cDNA sequence contains 
a total of 935bp in size. . 
From the cDNA sequences of xGH-A and xGH-B, the amino acid sequences of 
xGH-A and xGH-B were predicted. The xGH-A coding region encodes 214 amino 
acid residues. The xGH-B coding region encodes 208 amino acid residues. The 
hydrophobicity plots (Fig. 4.9) ofboth xGH-A and xGH-B were performed based on 
the predicted amino acid sequences. 
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CGA GCC GAA GAC CTT CAG TGA CCA CCT GTG GGA CAT TCA ACT TTC GAA CAC ATG 3 
M 1 
GCT ACA GGG TTC TGC TCT TCA TTT GGA CTC CTA GTC GTC TTG TTG CTG AAG AAC 57 
A T G F C S S F G L L V V L L L K N 19 
GTT GCT GAT GTT GGC GCT TTC CCA TCG GTG CCT CTG TTC AGT TTA TTC ACC AAT 111 
V A D V G A F P S V P L F S L F T N 37 
GCT GTA AGC AGG GCA CAG TAC CTT CAC ATG CTG GCT GCC GAC ACT TAC AGG GAT 165 
A V S R A Q Y L H M L A A D T Y R D 55 
TAT GAG AGG ACC TAT ATC CCA GAA GAG CAG AGG CAT TCT AAT AAG AAC TCC CAT 219 
Y E R T ^ Y I P E E Q R H S N K N S H 73 
GTG GTG TCCJTG^ TAC TCT GAA ACC ATC CCT TAT CCG ACA GAC AAA GAC AAC ACT 273 
V V S V c y Y S E T I P Y P T D K D N T 91 
CAC CAG AAG TCT GAC ATG GAA CTT TTG CGG TTC TCT CAG ACC CTC ATT CAA TCG 327 
H Q K S D M E L L R F S Q T L I Q S 109 
TGG CTG AAT CCA GTG CAA GCC CTG AGC AAA GTG TTC AGC AAC AAC CTG GTG TTT 381 
W L N P V Q A L S K V F S. N N L V F 127 
GGG AGT TCT GAT GTG TAC GAG AGG CTG AAG TAT CTG GAG GAA GGC ATC CAG GCT 435 
G S S D V Y E R L K Y L E E G I Q A 145 
CTG ATG AGG GAG CTG GAG GAT GGT AGC TTC CGC AGC TTC CCC GTC CTG AGA CCC 489 
L M R E L E D G S F R S F P V L R P 163 
CCG TAC GAG AGG TTT GAC ATC AAC CTG CGC AGC GAT GAA GCT CTG GTA AAA GTC 543 
P Y E R F D I N L R S D E A L V K V 181 
TAC GGC CTT CTG TCC|^T^ TTC AAG AAA GAT ATG CAC AAA GTG GAG ACC TAC CTA 597 
Y G L L S V S ^ F K K D M H K V E T Y L 199 
AAA GTC ATG A A G | 4 ^ CGG CGC TTT GTA GAA AGC AAC|^T^ ACC ATT TAA CTG TGT 651 
K V M K V ^ R R F V E S N V ^ T I * 214 
A7T TCT TTT CAA CAA CAG TTA GCC CTA TCC CCA GGG AGC TCT GCC TTC TAA CAT 705 
TGC CTT GTG TGG TAG GAA AGG GGA TAG GAT CCA AGT TGT ATA TTA CAT TTT GCC 759 
TAT AAA TTC TGG TCA GAA ACC CGT GTT TTT TTT TTT TTT TTG CTT TGT GTG TTG 813 
CTG AAT TTG TTG TAA ATT GTA CTT TAA ATA TAT TCT TAA TAA AGA TGC ATT TAC 867 
AGA AAA AAA AAA AAA AAA AAA AAA AAA 8 94 
Fig 4.5. The cDNA sequence of xGH-A. The sequences in italics are the untranslated 
regions. The letter in bold face is the start codon. The letters in circles are conserved 
cysteine residues. The symbol * indicates the stop codon. 
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CrA CTC AGC CGA GAA GCA TAT TCC CAT TCT CCA CCT GTT CGA CAG AGG ACT CCA - 7 
GAC AAC ATG GTC CCA GGA TTC TGT TCT TCG TTT GGA CTT CTA GTC ATC CTG TCC 48 
M V P G F C S S F G L L V I L S 16 
TTC CAG AAT GTT CCC GAT GTC GGT GGT TTC CCC AAT GTG CCT CTG TTC AGC CTC 102 
F Q N V P D V G G F P N V P L F S L 34 
TTC ACA AAT GCT GTG AAC AGA GCA CAA CAC CTG CAC ATG CTG GCT GCG GAT ATA 156 
F T N A V N R A Q H L H M L A A D I 52 
TAC AAA GAC TAT GAA CGA ACA TAT ATT ACA GAT GAC GTG AGA CGT TCA AGT AAG 210 
Y K D Y E R jr Y I T D D V R R S S K 70 
AAC TCG CAA GTG GTG T C T p C ^ TAC TCT GAA AAC ATC CCT GCT CCA ACG GAC AAA 264 
N S Q V V S \ j y Y S E N I P A P T D K 88 
GAC AAC ACT CAC CTA AAG TCT GAC ATG GAC CTT TTG CGA TTC TCG CTG ACC CTC 318 
D N T H L K S D M D L L R F S L T L 106 
ATT CAG TCT TGG CTG AAC CCA GTG CAA GCC CTT CAC AGG CTC TTT AGG AAT TCC 372 
I Q S W L N P V Q A L H R L F R N S 12 4 
GAT GTC TAC GAG AGA CTG AAG TAC CTT GAG GAA GGC ATC CAG TCC CTG ATC CGG 426 
D V Y E R L K Y L E E G I Q S L I R 142 
GAA CTG GAA GAG GGA AAC CTC CGC AGC TAC TCC TTT ATG AGA ACG CCT TAT GAA 480 
E L E E G N L R S Y S F M R T P Y E 160 
AGG TTG GAC ATC AAC ATG CGC ACT GAC GAC GGC CTT TTA AAA GTC TAC GGC CTC 534 
R L D ^ I N M R T D D G L L K V Y G L 178 
CTG TCC^TG^ TTC AAG AAA GAC ATG CAC AAA GTA GAG ACC TAC ATG AAA GTC ATC 588 
L ^ \ ^ ^ F K K D M H K V E T Y M K V I 196 
AAGjTGrt CGA CAC TTT GCC GAA AGC A A G ( ^ G ^ GTA ATT TAA CAT TTG CTG GTA AAC 642 
K V c y R H F A E S K K ^ V I * 208 
ACA AGT TTG CCA TAT CCC CTG ACC TAC CAG AAC ATC TAC AAA ACA CAG CTC TAT 696 
Grr ATA ACG CTG CCT CTC ATG GCA GAG AAA GGG GAC TGG ATA AAG TTA TAT ATT 750 
AGA TTA CAA GTT CAC CCC TCC TTC CCT GCT TTT CGT GCT GCT GAA ATC TTT TGT 804 
AAA TGA GGA TTT ATT ACA TAA TGC TAA ATA AAA GAT GCA TTT ACA GAT ACA TAA 858 
AAA AAA AAA AAA AAA AA 875 
Fig 4.6. The cDNA sequence of xGH-B. The sequences in italics are the untranslated 
regions. The letter in bold face is the start codon. The letters in circles are conserved 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 4 Cloning and Expression 
of xGH-A and xGH-B 
4.3.5. Protein expression and purification of recombinant xGH-A and 
xGH-B 
The coding regions without the signal peptides (mature protein) of xGH-A and 
xGH-B were amplified by PCR using high fidelity enzyme (Roche). The results are 
shown in Fig. 4.10. The discrete bands were purified and restriction enzyme cutting 
performed. The insert encoding for 189 amino acid residues was cloned in pQE30 for 
xGH-A. For xGH-B, the size of the insert encodes for 184 amino acids. Fig. 4.11 
shows that the xGH-A and xGH-B were successfully expressed in M15 cell. The size 
of xGH-A is slightly larger than xGH-B. The size of xGH-A was around 21kDa. The 
size of xGH-B was around 20kDa. In order to test the properties of these GH, these 
recombinant proteins were purified under denaturing condition (Section 4.2.5.1) Fig. 
4.12 shows the purification profiles of xGH-A and xGH-B. 
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4—’H“:t__ 
: M _ I 
M 1 2 3 4 5 6 7 8 9 10 11 12 
Fig 4.11. The expression of xGH-A and xGH-B in M15 cells. Lane M is the 
molecular weight standard. Lane 1-7 are the samples from 7 different clones of 
xGH-B expressing cells. Lane 8-12 are the samples from 5 different clones of xGH-A 
expressing cells. ⑷ _—". 1] 
w m L „ _ „ ^ _ i m 
M 1 2 3 4 5 6 7 8 ⑶ HHL i ^ 
H B K ： 、 : : _ M H 
M 1 2 3 4 5 6 7 8 
Fig. 4.12. The purification profiles of xGH-A (Panel A) and xGH-B (Panel B). Lane 
M: molecular weight marker. Lane 1: cell extract, Lane 2: flow through, Lane 3: wash 
with buffer pH 7.8，Lane 4: wash with buffer pH 6.0，Lane 5: wash with buffer pH 5.3. 
Lane 6-8: elute with buffer pH 7.8，100mM EDTA. 
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4.4. Discussion 
Partial fragments of xGH-A and xGH-B were successfully amplified from a 
Xenopus laevis pituitary cDNA library. In the cDNA library screening, the full-length 
xGH-A cDNA sequence was obtained. For around 450,000 pfu screened, the positive 
signals were observed to contain only the xGH-A cDNA sequence. However, no 
xGH-B cDNA clone can be found. The reason of the failure in the library screening 
for xGH-B may be due to the rare expression of xGH-B in adult Xenopus, or the probe 
for xGH-B was not specific enough for xGH-B. From the library screening, the 
xGH-A cDNA sequence was obtained. This sequence contained 945bp and the coding 
region was 645bp in size. This coding region encodes for 214 amino acid residues. 
Since the cDNA library screening did not yield the xGH-B cDNA sequence. 
Therefore, RACE methods were used. The degenerate nucleotide regions between 
xGH-A and xGH-B were used to design the primers. This can reduce the chance of 
mismatch amplification of xGH-A in the RACE. In the case of xGH-B, the cDNA 
sequence was 935bp in size. The coding region encodes for 208 amino acid residues. 
In GH, there are four cysteine residues forming two disulfide bonds. In the amino 
acid alignment of xGH-A and xGH-B with other GHs (Fig. 4.7)，these four cysteine 
residues were found to be highly conserved. This suggests that the cysteine residues 
provide an important functional role in protein folding to maintain a specific 
conformation (17). Since these cysteines are conserved in both xGH-A and xGH-B, 
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this suggests that the functional role of these cysteine seems to be conserved in 
amphibians well, indicating that the 3-D conformation of Xenopus GHs are similar to 
GHs of other species. 
The alignment of xGH-A and xGH-B with other GHs is shown in Fig. 4.7. In 
human helix 2 and helix 3 are connected by a small helix (sequences "KVFSN") and a 
loop. This small helix is conserved in most of the GH including xGH-A, but this 
sequence is missing in xGH-B. This sequence in xGH-B is "RLFRN". This sequence 
appears to be a loop region connecting helix 2 and helix 3： Therefore, in xGH-B, the 
small helix region is missing. Also the hydrophobicity prediction in Fig. 4.9 indicates 
that the difference is located in this region. The xGH-A has a longer and a slightly 
more hydrophobic region than xGH-B. A low homology (73%) is shown in the 
comparison between the amino acid sequence of xGH-A and xGH-B (Fig. 4.8). Taken 
together, these differences between xGH-A and xGH-B suggest that there is a 
potential functional difference between xGH-A and xGH-B. They may be regulating 
different functions in amphibians. 
The xGH-A and xGH-B mature proteins were expressed in a prokayotic 
expression system (pQE). Fig. 4.10 shows the expression xGH-A and xGH-B. Since 
the xGH-A polypeptide is longer than xGH-B, the size of the expressed xGH-A 
protein is slightly larger than xGH-B. These two hormones were further purified. The 
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vector pQE contains a poly-His sequence at the beginning of the transcription start 
site. This poly-His sequence was exploited in the purification process. The nickel 
resin column can capture the poly-His containing proteins. Therefore, the recombinant 
proteins can be isolated from the crude extract of the bacteria. Section 4.3.5 shows 
that the xGH-A and xGH-B have been successfully expressed and purified. These 
recombinant proteins can be used for bioassays in order to study the functional 
difference between these two isoforms of GH in amphibian. 
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Chapter 5 Molecular Cloning and Functional 
Expression of Goldfish Growth 
Hormone Receptor 
5.1. Introduction 
GH is involved in a broad range of biological functions. In mammals, these 
functions include the regulation of somatic growth and the maintenance of nitrogen, 
lipid, carbohydrate and mineral metabolism. In certain fish species, GH is involved 
not only in the functions described above, but also in osmoregulation (86, 87). In 
teleost fishes, as in other vertebrates, the mechanism of GH action is initiated by 
binding of the ligand to the membrane receptors. So far, there is no information 
regarding the structure of GHR in fish. Therefore, the present study aims at cloning 
the fish GHR cDNA using goldfish as a model. 
In this study, the goldfish GHR (gfGHR) cDNA was isolated from the goldfish 
pituitary and brain cDNA library. The tissue distribution of gfGHR in various tissue 
was studied by a semi-quantitative RT-PCR followed by Southern blot analysis. The 
coding region of gfGHR was expressed in cultured eukaryotic cells. The gfGHR 
expressing cell line was used to study the biological functions of gfGHR. 
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5.2. Materials and Methods 
5.2.1. Molecular cloning of the partial fragment of gfGHR 
5.2.1.1. Primer design 
The cDNA sequence of Xenopus laevis GHR provided a helpful information to 
predict the GHR sequence in fish. With the help of the sequence of rat, chicken, Rana 
and Xenopus laevis, the nucleotide sequence alignment was made. Five primers were 
designed for library PCR (The sequence alignment of primers were shown in 
Appendix). The sequences and relative positions of these primers are shown in Fig. 
5.1. The choose of usin nucleotide sequence alignment raher than amino acid 
sequence is based on several reason. First, the primers designed from amino acid 
sequence were tested before, however these primers failed to amplify the GHR 
sequence. Second, the nucleotide sequence alignment can suggest a new conserved 
region. Third, this alignment can reduce the degenerancy of the primers. This can 
reduce the non-specific amplification in the PCR. 
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Name 5， Sequences y Degeneracy 
FGHR-F1 TGG GTT GAR TTY ATW GAR YTS GA ^ 
FGHR-F2 GAT TCT CGM CGW RCC AGT TG 8 
FGHR-R1 WGC WGG WGT DAT RTC RCT HAC ^ 8 
FGHR-R2 GGW GTD ATR TCR CTH ACH WRR GC V m ~ 
FGHR-R3 |TCR CTH ACH WRR GCA TAR AAG TC 288 
Transmembrane domain 
5’ ^ g ^ ^ ^ ^ ^ j ^ ^ ^ ^ ^ ^ ^ ^ _ ^ ^ ^ ^ ^ ^ ^ ^ j j j g 2 j j j j j j j g ^ g j j g j j ^ ^ y 
" • ^ 
F1 (978) R1 (1448) 
~ > <— 
F2(1101) R2,(1445) 
R3(1421) 
Fig. 5.1. The sequences and relative positions of degenerate primers for amplifying 
gfGHR. The table above shows the sequences and degeneracy of these primers. The 
diagram below shows the relative positions of the primers. The numbers refer to the 5' 
end positions of the primers on the chicken GHR cDNA. 
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5.2.1.2. Library PCR of gfGHR partial fragment 
Using these degenerate primers, a set of PCR was performed to amplify the 
partial fragment of gfGHR. The goldfish pituitary and brain cDNA library was used 
as the template in PCR. This library was constructed using the ZAP Express cDNA 
Synthesis Kit and Gigapack Gold packaging extract (Stratagene). The vector used in 
library construction was pBK/CMV. PCR conditions were similar to the method 
described in Section 2.36，with some modifications. The conditions are shown in Fig. 
5.2. A nested PCR approach was adopted. In the first found PCR, FGHR-F1 and 
FGHR-R1 were used as the primers with 2 i^l of the cDNA library as template, and 
under the conditions as described in Fig. 5.2. In the nested PCR, 2 i^l of the first round 
PCR product was used as the template, and FGHR-F2 and FGHR-R3 as primers. The 
PCR conditions were the same as the first round. But the PCR was further optimized 
by changing the annealing temperature in a gradient manner. The annealing 
temperature ranged from 47°C to 58°C. After the optimization, a descrete band was 
purified from agarose gel (Section 2.14). Then the 3，end of the fragment was 
modified (Section 2.15) and ligated into pUC 18 vector (Section 2.16). The plasmid 
was transformed into DH5a competent cells. The DNA insert was confirmed by PCR 
screening. Finally, the fragment was sequenced by PCR sequencing (Section 2.21). 
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The PCR mixture contained the following: 
10X PCR Buffer 5^ il 
MgCl2 2^il 
dNTPs 1^1 
Forward Primer 15fil 
Reverse Primer 15^ il 
Taq 0.5nl 
Template (cDNA library) 2^ il 
H2O 9.5^1 
PCR conditions were as follows: 
Denaturing 94°C 2 min 
Cycling 94°C 1 min � 
40°C 30 sec r Repeat 35 cycles 
72°C 45 sec J 
Elongation 72°C 10 min 
Fig. 5.2. The conditions of the first round PCR amplification of a gfGHR partial 
fragment. The reaction volume was 50^il. The PCR was carried out in a Robocycler 
9600 gradient PCR machine. 
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5.2.2. Library PCR of gfGHR cDNA sequence 
From the nucleotide sequence of the partial sequence of gfGHR, four gene 
specific primers were designed. The sequences of these primers are as follows: gfFl-
GHR (5'- CCT TGA TGA CCC TGC AGA GAA G-3'), gfF2-GHR (5'-CCC TGC 
AGA GAA GAA TGA GAG-3'), gfRl-GHR (5'-CAT GTT AAC CCA GCT GGG 
CAC-3') and gfR2-GHR (5'-TTG AAT GGG CGT CTC CTT AAC-3'). In order to 
obtain the ftill-length sequence of gfGHR, a set ofPCR was performed. For the 5’ end 
sequence, gfRl-GHR and T3 (5'- ATT AAC CCT CACTAA AGG GAA-3') were 
used as the primers to amplify from the cDNA library. For 3’ end sequence, T7 ( 5 ' -
GTA ATA CGA CTC ACT AAT GGG C -3，) and gfFl-GHR were used as the 
primers to amplify from the cDNA library. The PCR conditions were similar to those 
described in Section 5.2.2 except that 2 i^l of the library was used as the template and 
the annealing temperature of the PCR was at 49�C for 1 min. Then 0.5 i^l ofthe PCR 
product was used as the template for the nested PCR. For the 5, end sequence, the 
primers used in the nested PCR were T3 and gfGHR-R2. For the 3’ end sequence, T7 
and gfGHR-F2 were used as the primers. The primer usage strategy is summarized in 
Fig. 5.3. The nested PCR was carried out at 50�C annealing temperature for 50 sec. 
The amplified PCR products were purified from agarose gel (Section 2.14)，modified 
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(Section 2.15) and ligated into pUC 18 vector (Section 2.16). Finally, the piasmids 
were prepared from transformed DH5a ceIIs and sequenced (Section 2.21). 
F l _ L ^ F 2 _ L T7 
pBK/CMV ^ ^ ^ ~ 
" ^ ^ R 2 — R i 
Fig. 5.3. The summary of the primers used in amplification of the 5，and 3’ end 
sequences of gfGHR. The upper line represents the 3'end amplification. First round 
PCR uses F1 (gfFl-GHR) and T7 as primers. The nested PCR uses F2 (gfF2-GHR) 
and T7 as primers. The lower line represents the 5, end amplifcation R1 (gfRl-GHR) 
and T7 were used as primers in the first round PCR. The nested PCR uses R2 (gfR2-
GHR) and T3 as primers. 
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5.2.3. Determination of 3，End and 5，End sequences of gfGHR cDNA 
From the sequences of the 5' and 3’ end nested PCR products, the sequence of 
the full-length gfGHR cDNA was obtained. Based on the partial sequence, the gfGHR 
cDNA sequence was finally amplified by PCR using a proof-reading polymerase, the 
High Fidelity PCR system (Roche). Two gene specific primers, gfGHR-UTRl (5'-
AAC TGT CAA CGT TTT TCA AC -3') and gfGHR-UTR-Rl were designed (5'-
TTA AAC TCT CTT GGC GAG CTA GC -3'). The goldfish liver first strand cDNA 
was used as template in this PCR. Goldfish liver first strand cDNA was prepared as 
follows. The total RNA of goldfish liver was prepared by TriPure Isolation Reagent 
(Section 2.2). Using the PolyATtract mRNA Isolation System (Section 2.3)，the 
mRNA was extracted from the total RNA. First strand cDNA was synthesized by the 
mRNA using the method described in Section 2.5. Oligo d(T)ig primer was used in 
the reverse transcription as the synthesis primer. The PCR reaction were as described 
the Fig. 5.4. The amplified product was subcloned into pGEM-T vector. The colonies 
were confirmed by PCR screening and positive clones were sequenced. The 
sequencing primers of gfGHR are shown in Fig. 5.5. 
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The PCR mixture contained the following: 
10X PCR Buffer with MgCl2 5^1 
dNTPs l^ il 
Forward Primer 2^ il 
Reverse Primer 2|il 
High Fidelity enzyme mix 0.4)_il 
Goldfish liver first strand cDNA 1^1 
H2O 38.6^ il 
PCR conditions were as follows: 
Denaturing 94°C 2 min . 
Cycling 94°C 1 min � 
56°C 45 sec [ Repeat 35 cycles 
72�C 2.5 minJ 
Enlongation 72°C 10 min 
Fig. 5.4. The PCR amplification of gfGHR full length sequence. The reaction volume 
was 50^il. The forward primer was gfGHR-UTRl. The reverse primer was gfGHR-
UTR-R1. PCR was carried out on a Pekin Elmer Gene Amp 9600 PCR machine. 
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Transmembrane domain 
5'UTR Extrac^ UMlftr dprnain hitraccUular domain 3'UTR 
_ i i ； i ~ r 
— i i 1 M 
~ T > ~r> ~ > -^TT- < ~ < ~ 
T > -¢ - 9 ~ » ~"» _ ^ 5 7 
8 11 12 .. 6 “ <— <— 
3 ~ » 
14 
Name 5’ Sequence 3’ Position 
GfGHR-SEQ5 T G A T C C G G A T G A A C G A A C T G 1 — 
GflaHR-Start ATG CGC GGC CGC ATG GCT TAC TCT CTC TTG CTC AG ~2 
GfGHR-R240 TGG ACA CTC CTG CCA CTC AG 3 — 
GfGHR-SEQ631 "kTC TGG ACC TCC TAC TGC ATT CAG ~ “ 
GfGHR-SEQRl AAT CAC TGG TGG ACA CCA GGT ACT C 5 
GfGHR-1240R A T G T C T G T T G G A C G C C A A G G 6 
GfGHR-Stop ^ T G CGG GCC TCA CGG GGT CAG GTT TCC CAG ~ “ 
GfGHR-SEQR530 T G A C C C G G T A C T G A A C C T G 8 
GfGHR-SEQ650 GGT GCG CTG CAA GAT GAC AG 9 
GfGHR-SEQR2 TAT TAC CAT GAA CCT CTG CTG ~10 — 
GK)HR-SEQ950 CGG ACT TCT ACC ATG AGG AT 11 
GfGHR-SEQ549 CT6 GTT TCC AGA AGC AGC TCG 12 
GfGHR-SEQ1590 AAG TGA TTC CCA GAT GCC T 13 
GfGHR-SEQ1800 GCC AGG CAA CTT TCC GCC AAC GTG ~14 
Fig. 5.5, The sequencing primers of gfGHR. The figure above shows the relative 
positions of the primers (1-14). The table shows the names and sequences ofthese 
primers. 
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5.2.4. Tissue distribution of gfGHR 
5.2.4.1. Animals and tissues 
Adult goldfish {Carassius auratus) were purchased from a local fish market. 
After the goldfish were killed, different tissues were isolated and frozen immediately 
in liquid nitrogen. All the tissues were store at -70°C until use. 
5.2.4.2. Semi-quantitative RT-PCR 
The tissue distribution of gfGHR was performed by a semi-quantitative RT-PCR 
followed by Southem analysis. The total RNA of different goldfish tissues were 
prepared by TriPure reagent (section 2.2), followed by mRNA purification on a PolyA 
Tract System (Section 2.3). First strand cDNA was synthesized from 0.5 i^g of mRNA. 
The first strand cDNA was used as the template for the RT-PCR. Two gene specific 
primers gfGHR-SEQ549 (5'-CTG GTT TCC AGA AGC AGC TCG -3') and gfGHR-
SEQR1 (5'-AAT CAC TGG TGG ACA CCA GGT ACT C -3，) were used. The house 
keeping gene, goldfish P-actin was used as the control. The sequences of the goldfish 
P-actin primers were gfpACT-F (5'- GAC GAG GCC CAG AGC AAG AGA GG -3’ 
and gfpACT-R (5'- CTG CTT GCT GAT CCA CAT CTG CT -3'). The PCR 
conditions were as follows: 2 min at 94°C, then 25 cycles of 45 sec 94°C, 45 sec at 
56�C (60°C for P-actin) and 2 min at 72°C, finally a 10 min elongation at 72�C. The 
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PCR products were analyzed on a 1% agarose gel and blotted onto a nylon membrane 
by vacuum transfer method (Section 2.8). The PCR product of gfGHR-SEQ549 and 
gfGHR-SEQRl on the cloned gfGHR plasmid as the template was used as the probe 
in the Southern analysis. The DNA transferred membrane was hybridized with this 
gfGHR gene specific probe ovemight (Section 2.11). After the hybridization,the 
membrane was washed with 2X SSC 0.1% SDS at room temperature for 15 min twice, 
and then by IX and O.lX SSC with 0.1% SDS at 65°C for 15 min twice again. The 
membrane was dried and the result of the Southern blot was detected and analyzed on 
a Bio-Rad Molecular Imager System (GS-505). 
5.2.5. Functional expression of gfGHR in CHO-Kl cell 
5.2.5.1. Construction of an expression vector containing gfGHR 
The coding region was amplified from the goldfish liver first strand cDNA by 
two gene specific primers, gfGHR-Start (5'- ATG CGC GGC CGC ATG GCT TAC 
TCT CTC TTG CTC AG -3') and gfGHR-Stop (5'- ATG CGG GCC TCA CGG 
GGT CAG GTT TCC CAG -3'). The gfGHR-Start primer contains a Not I site and 
the gfGHR-Stop primer contains a Apa I site. The amplified product was subcloned 
into pGEM-T vector by TA cloning (Section 2.39). The coding region of gfGHR was 
released by restriction enzyme cutting {Not I and Apa I), as described in Section 2.37. 
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The buffer used in the reaction was the Multi-Core buffer. Both the gfGHR-
containing clone and the pRc/CMV vector were digested. The products were purified 
by QIAEX II kit (Section 2.14). The released fragment from the gfGHR-containing 
clone was ligated with the digested pRc/CMV vector and transformed into DH5a 
cells. 
5.2.5.2. Functional assays of gfGHR expressed on CHQ-K1 cell 
CH0-K1 were cultured at 37°C with 5% CO2 in MEM with 10% FCS, 100 
units/ml penicillin, lOOmg/ml streptomycin. For the transfected CH0-K1 cells, 
500^ig/ml G418 was added into the culture medium. Two cell lines, one transfected 
with the control vector pRc/CMV (CHO-pRC), and another transfected with the 
gfGHR-containing vector pRc/CMV-gfGHR (CHO-gfGHR), were generated. The 
expression vectors were transfected into CH0-K1 cells with the Lipofectamine Plus 
reagent (Section 2.39). The CHO-pRC cells were used as the negative control in the 
functional assays. The stable cell line expressing the gfGHR was established by the 
antibiotic (G418) selection for 3 weeks. The expression of gfGHR in transfected cell 
was confirmed by RT-PCR. The polyA+ mRNA of the CHO-pRC and CHO-gfGHR 
cells were used to synthesize of the first strand from the template. The primers and 
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PCR conditions were the same as in the tissue distribution studies except using 30 
cycles in the PCR amplification. The positive control was done by amplify the p-actin. 
5.2.5.3. Proliferation assay 
A cell proliferation assay was performed as a functional assay of the gfGHR. The 
tetrazolium salt MTT assay (Section 2.27) was used for this proliferation assay. CHO-
pRC or CHO-gfGHR cells were seeded into 96-wells plates in a density of 1.5 x 10^  
I 
cells per well. The cells were starved for 16 h in MEM without FCS. After starvation, 
different doses ofhGH in MEM were added. For each dose ofhGH, 5 replicates were 
performed. The CHO-pRC cells were used as the control in this experiment. The cells 
were incubated for 24 h. The hormone-containing medium was removed. Then 50 i^l 
of MTT (5mg/ml) were added. After 2 h incubation at 37°C, 150^1 ofDMSO were 
added to lyse the cells. O.D.540 were recorded an on ELISA plate reader. 
I 
5.2.5.4. Spi luciferase assay 
The method is described in the Section 2.28. The Dual-Luciferase Assay System 
of Promega was used. The CHO-pRC and CHO-gfGHR cells were plated on 24-well 
plates until 50-80% confluence. The Spi 2.1 promoter-containing pGL2 vector and 
pRL/CMV vector were transfected into the cell lines by Lipofectamine reagent. 
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Meanwhile, the transfection of pGL-Basic was used as the negative control of the 
reaction and pGL-Control was used as the positive control for the experiment. After 6 
h of transfection, 1ml of recombinant hGH (250ng/ml), recombinant goldfish GH 1 
(gfGHl) (250ng/ml) or recombinant goldfish GH 2 (gfGH 2) (250ng/ml) were added 
and incubated for another 40 h. Then the hormones were removed and the cells 
washed. The cells were lysed by 50^1 of lx Passive Lysis Buffer. The lysate was 
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5.2. Results 
5.3.1. PCR amplification of the partial sequence of gfGHR 
The partial fragment of gfGHR was amplified from the goldfish pituitary and 
brain cDNA library by PCR. Five degenerate primers were used. The first round PCR 
results are shown in Fig. 5.6. PCR using FGHR-F2 as the forward primer failed to 
amplify any band. In the case of FGHR-F1, this forward primer amplified 3 bands 
(420bp, 350bp and 150bp respectively) with FGHR-R3 and another 3 bands (300bp, 
200bp and 150bp respectively) with FGHR-R2 and 2 bands (400 and 250bp) with 
FGHR-R1. The band of 420bp using FGHR-F1 and FGHR-R3 as primers was the 
closest to the expected size (450bp). In order to obtain a discrete band, a nested PCR 
was performed. The PCR was performed in a gradient of annealing temperatures 
using the FGHR-F1/R1 PCR products as template. The annealing temperatures ranged 
from 47°C to 58�C. The result ofthe nested PCR is shown in Fig. 5.7. Nested PCR 
using FGHR-F2/R3 as primers amplified a discrete band 398bp in size. The size of 
this band was the closest to the expected size. This band was subcloned into pUC 18 
vector by blunt end ligation. After sequnecing, the sequence of the partial fragment 
was submitted to perform Blast search (NCBI). The result suggested that this 
fragment is homologous to GHR of other species. 
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^ ^ ^ ^ ^ ^ ^ ^ ^ m j m j i i i ^ i <-6oobp 
B H mtM^ 
1 2 3 M 4 5 6 
Fig. 5.6. The first round PCR of the gfGHR partial fragment, using the goldfish 
pituitary and brain cDNA library as template. Different primers were used, Lane 1: 
Fl/R3 primer; Lane 2: Fl/R2; Lane 3: Fl/Rl; Lane 4: F2/R3; Lane 4 F2/R3; Lane 5: 
F2/R2; Lane6F2/Rl. 
i ^ H B -
Q^Bgj|jBB^ ^^ 3 
1 2 3 4 5 6 7 8 9 10 11 12 M M 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 
— = = = ^ ^ ^ • — = = : a ^ ^ ^ c = = ^ M I ^ = = : 3 ^ ^ 0 ^=3a^^ 
Fl/Rl Fl/R2 Fl/R3 F2/R2 F2/R3 
Fig. 5.7. The nested PCR of the gfGHR partial fragment. All the PCR used FGHR-
Fl/Rl first round PCR product as the template. The annealing temperatures were 
47°C，49°C, 51°C, 53°C and 57°C. The annealing temperature increase was indicated 
in the figure from left to right. Lane M was the 100bp marker. Page 121 
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5.3.2. The library PCR of gfGHR cDNA sequence 
Based on the partial sequence of gfGHR, the 5’ and 3’ cDNA end sequences of 
gfGHR were obtained by PCR using gfGHR cDNA library as the template in a nested 
approach. For the 5’ end cDNA sequence, T3, gfRl-GHR and gfR2-GHR were used 
as the primers. For the 3’ end cDNA sequence, T7, gfFl-GHR and gfF2-GHR were 
used as the primers. The result of the first round PCR is shown in Fig. 5.8. For the 3’ 
end sequence, the nested PCR amplified three discrete bands with sizes of 1200bp, 
850bp and 550bp respectively (Fig. 5.9). For the 5’ end sequence, gfR2-GHR and T3 
amplified several bands. The size of these bands were 1150bp, 500bp, 400bp and 
200bp respectively. The band with 1150bp in size was purified and subcloned into 
pUC18 vector. After sequencing, this fragment was found to contain the gfGHR 
partial sequence and the 5' cDNA end sequence of gfGHR. In the case of3 ' end PCR, 
the primers gfF2-GHR and T7 amplified several bands with 1500bp, 900bp, 500bp, 
400bp and 250bp in size. The largest fragment with 1500bp in size was purified and 
subcloned. After sequencing, this fragment was confirmed to contain the partial 
sequence of gfGHR and the remaining 3’ cDNA end sequence of gfGHR. 
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一 _ 
850b^ ^ ^ ^ ^ ^ ^ 1 
550Vr^  ^ ^ k ^ ^ H 
• 
1 M 2 
Fig. 5.8. The first round library PCR of the gfGHR using vector primers and gene 
specific primers. Lane 1 was the PCR using gfFl-GHR and T7 as primers. Lane M 
was the 100bp marker. Lane 2 was the PCR using gfRl-GHR and T3 as primers. 
'..'• ’i 
L: 
旧 令 1 5 0 
115"^ t i i , - t o ||||,二 ^ 9 0 0 
?mBf^g^M 
500^ M 明 ^ 500 
L - ' “‘ ' ' 'H^t3BSSS9 ^ 400 
4 0 0 ~ > ^ g H ^ | ^ ^ m 
^ ^ ^ ^ ^ ^ ^ ^ ^ • 250 
200~> ^ ^ ^ ^ ^ ^ ^ 1 
1 M 2 
Fig. 5.9. The nested library PCR of gfGHR using vector primers and gene specific 
primers. Lane 1 was the nested PCR of FlA7 using gfF2-GHR andT7 as primers. 
Lane M was the 100bp marker. Lane 2 was the nested PCR of RlAT3 using gfRl-
GHR andT3 as primers. 
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5.3.3. The sequence of gfGHR 
In order to confirm the sequences of the PCR products obtained in Section 
5.3.2 actally belong to the same mRNA transcript of gfGHR, two gene specific 
primers (gfGHR-UTRl and gfGHR-UTR-Rl) were used to perform a PCR using 
High Fidelity enzyme system as polymerase. The High Fidelity enzyme can reduce 
any PCR error. The result of this PCR is shown in Fig. 5.10. A band with around 
2.4kb in size was observed. This band was subcloned into pGEM-T vector. The 
sequence of this fragment was found to be identical t6 the sequence of the PCR 
product from Section 5.3.2. Therefore, the sequences of 5'end and 3’ end PCR 
obtained in section 5.3.2 must belong to the same mRNA of gfGHR. Combining the 
sequences of the 5' end, the 3’ end and the High Fidelity PCR product, the sequence 
of full-length gfGHR cDNA was obtained. The nucleotide sequence and the predicted 
amino acid sequence is shown in Fig. 5.11.The amino acid alignment of gfGHR with 
other GHRs is shown in Fig. 5.12. 
l d H H ^ ^ H ^ ^ ^ ^ H H H 
3 0 5 4 b p ~ ^ B ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ B B 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ S < — 2416bp 
2036bp ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ 
• 
Fig. 5.10. The High Fidelity enzyme PCR of gfGHR. Lane 1 is the negative control of 
PCR. Lane M is the lkb marker. Lane 2 is the High Fidelity enzyme PCR. This PCR 
shows a discrete band with 2.4kb in size. 
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5' cccaattaaccctcactaaagggaacaaaagctggagct -427 
cgcgcgcctgcaqgtcgacactagtggatccaaagaattcggcacgaggcgc^tgcccccactccctctq -356 aacaaatccctqtcaacgtttttcaacgcgcqttatacctaaaaaccctgcaacgcgttcagctgttttcc -285 cgaaacgatgttcgggtgattctgagtttqatctgaccacgtttttacatcgtttaaaaqgggagaacacc -214 gaqagacccacaacacgcaaqtctgttgatccggatgaacgaactgttgagaaagtaaaact^caacaga -14 3 
gtEcEct5gcggacaacttctctggagctgagggtgtgcaaagctcgtggagcacagggcagtaaacaaEt -72 
誕巧魏灘'银9雜哈『鍋觀!魄搬龍離9潮3辯。鑑3脇 -1 
M A Y S L L L S L L Y L G M L C G N 18 
GGA CTG GTG TCT GCA AGA TCT GAG CTG TTC ACT CCA GAT CCA AGC AGA GGA CCT 108 G L V S A R S E L F T P D P S R G P 36 
CAT TTT ACG GGC ^GC)CGC TCC AGA GAG CAG GAG ACC TTC CGT fGC^TGG TGG AGC 162 H F T G \ c y R S R E Q E T F R X^y W W S 54 
GCT GGG ATC TTC CAG AAC CTC ACC GAG CCT GGG GCT CTC AGG GTC TTC TAC ATG 216 A G I F Q N L T E P G A L R V F Y M 72 
ACA AAA CAT GCC CTC TCT GAG TGG CAG GAG ^^GT^CCA GAC TAC ACA CGT ACT GTG 270 T K H A L S E W Q E ^ ^ P D Y T R T V 90 
A ^ AAC GAG ^ ^ TAC TTC ^AC AAG ACC TTC A ^ CAG ATC T ^ ACC TCC TAC ' ^ ^ 324 
ATT CAG CTG CGC TCA GTT CGT GAG AAC ATA ACC TAT GAT GAG GCC tGC^TTT ACG 378 
I Q L R S V R E N I T Y D E A V ^ F T 128 
GTG GAG AAC ATA GTG CAT CCT GAC CCG CCA ATT GGG CTH iAP frGG ACT CTG CTG 4 3 2 V E N I V H P D P P I G L lN W T L L 144 
AAT| GTG AGT CGC TCA GGG TTG CAC TAT GAC ATC CTT GTG CGC TGG GCT CCC CCT 486 
_JiJ V S R S G L H Y D I L V R W A P P 162 
CCG TCA GCA GAT GTG CAG ATG GGC TGG ATG AGC CTG GAG TAC CAG GTT CAG TAC 540 P S A D V Q M G W M S L E Y Q V Q Y 180 
CGG GTC AOA AAC |AAC|TCC CAC TGG GAA ATG CTG GAC CTG GAG AGT GGC ACA CAG 594 R V R N i N i S H W E M L D L E S G T Q 198 
CAG TCC ATC TAC GGT TTA CAT ACT GAC AAA GAG TAT GAA GTC CGG GTG CGC TGC 648 
Q S I Y G L H T D K E Y E V R V R C 2 1 6 
AAG ATG ACA GCC TTT GAC AAC TTT GGT GAA TTC AGT GAC AGC ATC ATT GTG CAT 702 
K M T A F D N .E…….G.……£……_E…….S. D S I .1 V H 234 
GTG GCA CAG ATA CCA AGC AAA GAA TCA ACG TTC CCG ACG ACG TTG GTG TTG ATT 756 V A Q I P S K E S T F P T T L V L I 252 
TTT GGA ATG ATT GGA GTG GTG ATT CTT CTT GTC CTC CTC ATC ^TC TCT CAG CAG 810 
I.__G M I G V V I L L V L L I F S Q Q 270 
CAG AGG TTG ATG GTA ATA TTT TTA C^a rrr aTT r r r r:ra r r r &&z^  aTT &&& r ^ r 864 
Q R L M V I F L iV P 丄 P A P K.丄 K li I 288 
.^^^ GAC CCA GAG CTG CTG AAG AAT GGA AAG CTT GAC CAG CTC AAT TCT TTG CTG 918 UJD D P E L L K N G K L D Q L N S L L 306 
AGC AGT CAG GAT ATG TAC AAG CCG GAC TTC TAC CAT GAG nfiT rr& Tf^ r: OTn nan 972 
S S Q D M Y K P D F Y H E I U P W V bH 324 
TTP arr rar: r r n r:nr- r-TT oaT nar- CCT GCA GAG AAG AAT GAG AGC TCT GAT ACA 1026 
I t- 丄 U L. U U U U I P A E K N E S S D T 342 
CAA CAT CTG CTG GGC TTG TCC CGC TCA GGC TCT TCT CAC GTC CTG AAT TTC AAA 1080 
Q H L L G L S R S G S S H V L N F K 360 
AGC GAC GAT GAT TCA GGT CGT GCT AGC TOO TAf GAC CCA GAA ATC CCA AAT CCC 1134 S D D D S G R A S C Y D P E I P N P 378 
GAG GAC TTG GCT ACC CTT CTG CCT GGC CAT TCC GGA CGG GGA GAT AAC CAC CCA 1188 E D L A T L L P G H S G R G D N H P 396 
CTG GTT TCC AGA AGC AGC TCG TCC ATC CCT GAC CTT GGC GTC CAA CAG ACA TCA 1242 L V S R S S S S I P D L G V Q Q T S 414 
GAA GTT AAG GAG ACG CCC ATT CAA AAG CAA CCC GCT GTG CCC AGC TGG GTT AAC 1296 
E V K E T P I Q K Q P A V P S W V N 4 3 2 
ATG GAC TTT TAT GCC CAA GTA AGC GAT TTC ACA CCA GCA GGA GGA GTG GTG CTT 1350 M D F Y A Q V S D F T P A G G V V L 450 
TCA CCT GGA CAA CTG AAC AGC TCT CTG GAG AAA AAG AAG GAA GAA GAG AAT GAG 1404 
S P G Q L N S S L E K K K E E E N E 468 
AAG AAG ATA CAG TTC CAG CTG GTT TCC GAT GGA Grr TAf ACC TCA GAG AAC ACA 1458 
K K I Q F Q L V S D G A Y T S E N T 486 
GCC AGG CAA CTT TCC GCC AAC GTG CCG TCC AGC CCT GGT CCT GAG CAG GGG TAC 1512 A R Q L S A N V P S S P G P E Q G Y 504 
CAA ACA TTT CCA ACC CAA GCT GTT GAG GGA ACC TCT GAA CGG GGA GTA CCT GGG 1566 
Q T F P T Q A V E G T S E R G V P G 5 2 2 
TGT CCA CCA AGT GAT TCC CAG ATG CCT TAC CTC CTT CCT GAA GCT CCT CCA TCC 1620 
C P P S D S Q M P Y L L P E A P P S 540 
CCC ATA TTG CCC CCC GTG TCA GAf TAT ACT GTG GTG CAG GAA GTG GAT GCC CAG 1674 
P I L P P V S D Y T V V Q E V D A Q 558 
CAT AGC CTC CTC CTG AAT CCT CCT TCC TCA CAG CCT GCG ATA TGC CCT CAC AGC 1728 H S L L L N P P S S Q P A I C P H S 576 
CCA AAC A ^ CAC CTC CCA G ^ ATG C ^ ACC ATG CCC ATG GgA TAT CTC ACC CCA 1782 
GAC TTT CTC GGA AAC CTC ACC CTO t|aaggaactaaaaggtgcaaagttcatggtcttgttgt 1845 
actqtaccttctcactgctgggallcM^|ttgcatgaatggcgcqacacqggatqgaaatcctgcacgatt 1917 a，tEtcEctgctgt:acgctacaa.Satggiaggagct:gaaaagg&£"attt€Sfgt€fgctgttg^igtlgtq 1989 ctacgctagctcgccaagagagtttaaatgtgtEgcatttacaatcagaaacaEcagctggttacalgcata 2061 .a aaaaasaa a^aaa 3 ~ 2 0 7 5 
Fig. 5.11. The cDNA sequence of jgfGHR. The sequence in small cap is the 
untranslated region. The letter in boldwas start codon. The letters in circles were 
conserved cysteine residues. The letter with an * was stop codon. The YGEFS motif 
was underlined by dot line. Boxl and Box 2 regions are highlighted by boxes with 
shadows. The signal peptide was underlined by a single l i n e . ^ e conserved potential 
Asn-lmked glycosylation sites are highlighted by open boxes. The transmembrane 
domain is underlined by a double line. 
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Chapter 5 Molecular Cloning 
and Functional Expression of gfGHR 
A phyIogenetic analysis was performed to compare the predicted amino acid 
sequence gfGHR and other GHR (Fig. 5.14). A hydrophobicity plot ofthe predicted 
amino acid sequence of gfGHR was performed using the Kyte and Doolittle method 
(64). The result is shown in Fig, 5.13. Two major hydrophobic regions were detected, 
one at the beginning and the other in the middle of the sequence. The first 
hydrophobic region represents the signal peptide and the other hydrophobic region 
represents the transmembrane domain of the gfGHR. 
File: GFGHRED.AMI 1 - 602 
Table: K7te & DooIlttle 
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Fig. 5.13. The hydrophobicity plot of the goldfish GHR. The plot was obtained by 
the method of Kyte and Doolittle (64), with a window setting of 10 amino acids, 
using the DNasis (Hitachi) software. The number in the X and Y axis indicate the 














































































































































































































































































Chapter 5 Molecular Cloning 
and Functional Expression of gfGHR 
5.3.4. Tissue distribution of gfGHR 
The expression level of gfGHR in goldfish was studied by RT-PCR followed by 
Southern blot analysis (Fig. 5.15). Eleven tissues had been studied. From the results of 
Southern blot analysis, the relative expression was represented using the liver level as 
100%. The amplification of p-actin was used to normalize the amount of first strand 
cDNA in the experiment. All tissues examined were found to express P-actin mRNA 
in about the same level indicating the integrity of the first strand cDNA produced. 
Panel C of Fig 5.15 shows the relative expression level of gfGHR in different tissues. 
Goldfish liver was shown to possess the highest expression level of GHR. The next 
highest value was hypothalamus (86.6%). Brain (30.4%), kidney (45.6%) and male 
gonad (48.5%) also had a significant expression of GHR. Lower levels of expression 
were observed in the gill (22.5%), intestine (27.7%) and pituitary (28.1%). Weak 
expression of GHR was detected in the female gonad (10.5%), gall bladder (19.4%) 
and heart(19.2%). 
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Fig. 5.15 Tissue distribution of GHR in goldfish. This was carried out by RT-
PCR/Southem blot analysis. Panel A: Southern blot signals ofthe gel from RT-PCR 
using gfGHR gene specific primers. Panel B: control RT-PCR using gfP-actin primers. 
The designation of the different alnes are as follows: lane 1，male gonad; lane 2, 
female gonad; lane 3, intestine; lane 4，gall bladder; lane 5, heart; lane 6, brain; lane 7, 
liver; lane 8, kidney; lane 9，gill; lane 10，pituitary; lane 11, hypothalamus. 
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5.3.5. Proliferation assay 
In order to study the biological function of gfGHR, a stable cell line expressing 
the gfGHR was generated. A cell line transfected with the control vector pRc/CMV 
was used as a control cell line in the experiments. The expression of gfGHR in 
transfected cell was confirmed by RT-PCR. The result of the PCR is shown in Fig. 
5.16. P-actin was amplified in both the CHO-gfGHR and CHO-pRC cells indicating 
the integrity of the first strand cDNA produced. In the PCR using gfGHR gene 
specific primers, a 350bp band was observed only in CHO-gfGHR cells. This 
indicates that the gfGHR mRNA was expressed only in the CHO-gfGHR cells but not 
in the control CHO-pRC cells. The biological function ofthe gfGHR was assessed by 
the proliferation assay. In this assay, hGH was used to stimulate the growth of the 
transfected cell. The dose used in this assay ranged from 0 to 800ng/ml. The results of 
the proliferation assay are shown in Fig. 5.16. The CHO-gfGHR cells were induced to 
proliferate by hGH and have a peak proliferation value at 200ng/ml hGH with a 
155.3% increase in proliferation. This stimulation remained at a high value at 
400ng/ml and 600ng/ml GH. At 800ng/ml GH, the proliferation of CHO-gfGHR 
slightly dropped to 134.9%. The CHO-pRC cells did not respond to GH at all with the 
GH concentrations tested. 
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Fig. 5.16. Expression and functional assay of the expressed gfGHR on the transfected CHO-Kl cells. 
Panel A shows the results of the RT-PCR analysis: lane M, 100bp marker; lane 1 RT-PCR of 
performed on control CHO-Kl cells transfected with pRc/CMV vector alone using gfGHR gene 
specific primers; lane 2, RT-PCR ofgfGHR primers using the gfGHR-pRc/CMV transfected CHO-Kl 
cells first strand cDNA as template; lane 3, negative control for the gfGHR amplification; lane 4，RT-
PCR of CHO-Kl cells transfected with pRc/CMV vector alone using P-actin primers; lane 5’ the 3-
actin RT-PCR amplification of gfGHR-pRo'CMV transfected CHO-Kl cells; lane 6’ the negative 
control ofp-actin amplification. The band located at 398bp represents the gfGHR PCR product and the 
912bp fragment represents the p-actin PCR product. Panel B shows the proliferation assay of 
transfected cells induced by hGH Results were expressed as a percentage ofthe signal observed in the 
control cells in the absence ofhGH. Data are the tnean ±SD oftwo independent experiments performed 
in replicates of 5. 
Page 134 
Chapter 5 Molecular Cloning 
and Functional Expression of gfGHR 
5.3.6. Spi luciferase assay 
The Spi 2.1 promoter region is a reported responsive element to GH induction 
(70). The Spi 2.1 promoter-containing pGL2 vector was kindly provided by Dr. Nils 
Billestrup of the Hagedom Research Institute in Denmark. The result is presented in 
percentage increase of luciferase activity compared to the induction of CHO-gfGHR 
or CHO-pRC without GH added. From the results (Fig. 5.17), the hGH had the 
highest stimulation on CHO-gfGHR. The hGH treated cell had 100.15% increase of 
the luciferase activity. Recombinant gfGH I also stimulated the activity by 78.83%. A 
weaker response (53.78%) can be observed for recombinant gfGH II. In the case of 
the CHO-pRC cells, no induction was observed in all the hormones tested. 
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Fig. 5.17 Spi promotor luciferase assay of gfGHR expressed CH0-K1 cells. The hormones (hGH, 
gfGH I and gfGH II) were at 250ng/ml. The percentage induction of luciferase activity was calculated 
by using the activity of CHO-gfGHR and CHO-pRC cells without GH treatment as the baseline. 
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5.4. Discussion 
In the present study, goldfish GHR cDNA was cloned by PCR. In the PCR, the 
primer design was based on the conserved nucleotide sequence of GHR. This method 
was different from the amino acid sequence alignment to find the conserved regions 
for design primer. Using nucleotide alignment can sharply reduce the degeneracy of 
the primers. Therefore, the chances of non-specific binding of the primers can be 
drastically reduced. Since the amphibian was closer to fish in evolution, the alignment 
included the amphibian {Xenopus laevis) GHR sequence', thus further increasing the 
accuracy in displaying the conserved regions in GHR across species. Using this 
approach, the FGHR primers successfully amplified the partial fragment gfGHR from 
the cDNA library. The partial fragment encoded 398bp cDNA sequence of gfGHR. 
By the Blast search from NCBI, this sequence had the highest homology with chicken 
GHR. 
Based on the partial sequence of gfGHR, the 5，and 3' cDNA end were amplified 
from the gfGHR cDNA library. Before the PCR method was attempted, library 
screening was employed to obtain the ftill-length gfGHR cDNA sequence. However, 
no positive clone was found after the screening. This may be due to the low 
expression level of gfGHR in the brain and pituitary library. Because PCR can 
amplify template present at very rare amounts, the PCR method was used to isolate 
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the gfGHR cDNA sequence. After the amplification, a total 2540bp of the gfGHR 
cDNA sequence was found (Fig 5. 11). In order to prove that the 3’ end fragment and 
the 5 'end fragment belong to the same mRNA molecule. Two gene specific primers 
(gfGHR-UTRl and gfGHR-UTR-Rl) designed at the 5，and 3’ UTR regions to 
perform PCR amplification. The result in Fig. 5.10 shows the successful amplification 
of this PCR. This suggests that the cDNA sequences of 3，and 5'ends of gfGHR 
belong to the same gfGHR mRNA molecule. 
Within the 2540bp of gfGHR sequence, 1806bp is the coding region. This coding 
region of gfGHR encodes for 602 amino acid residues. A hydrophobicity plot was 
performed on the predicted amino acid gfGHR sequence (Fig. 5.13). The result ofthe 
hydrophobicity plot shows two highly hydrophobic regions. The first region is located 
at the beginning of the sequence, from amino acid 1 to amino acid 24. This is 
probably the signal peptide of gfGHR. The second region is located in the middle of 
the sequence at amino acid 244 to 268. It is the transmembrane domain ofgfGHR. 
An amino acid alignment of gfGHR with other GHRs is shown in Fig. 5.12. 
From the alignment, several characteristics can be noticed. These include: six 
conserved cysteine residues, four potential Asn-linked glycosylation sites, the FGEFS 
motif, the Box 1 region, Box 2 region and the conserved tyrosine residues. 
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In the extracellular domain, the seven cysteine residues were highly conserved in 
mammalian and avian species. The first six conserved cysteines formed 3 disulfide 
bonds. These three disulfide linkages are believed to play a structural function in the 
GHR extracellular domain (17). These three disulfide bonds are also highly conserved 
in gfGHR. The first bond is formed between Cys 41 and Cys 51. The other two bonds 
are formed between Cys 83 and Cys 94, and bewteen Cys 108 and Cysl26. The 
seventh cysteine is an unpaired cysteine. Although this cysteine is highly conserved in 
mammalian and avian species, the function of this cysteine is still unclear. However, 
in amphibian [Xenopus laevis) and fish (goldfish), this unpaired cysteine residue is not 
in the same position as in others GHRs. Indeed, this cysteine is located at amino acid 
216 before the FGEFS motif. 
Other than the conserved cysteine, there are four conserved potential N-linked 
glycosylation sites (NXS/T) located at position 97，140, 145 and 184. In the case of 
porcine GHR (79), substitution of the five Asn residues with Gln reduced 20-fold the 
binding affinity of porcine GHR analogs to '^^I-labeled porcine GH. This suggests 
that Asn-linked glycosylation is necessary for the maintenance of a high affinity 
binding state. In goldfish, two other Asn-linked glycosylation sites are found. The first 
one is located at position 60. This site is also found in Xenopus and pigeon. The 
second site is located at position 117. This site shows no homology to other GHRs. 
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Since this two sites are conserved in Xenopus and goldfish, therefore it may be 
responsible for defining the GHR binding characteristics of lower vertebrates. Further 
experiment was necessary to confirm this. 
Other than cysteines and N-glycosylation sites, the extracellular domain of 
gfGHR has another conserved feature, and this is the YGEFS motif. The whole motif 
is highly conserved in all GHR. But in avian, amphibian and fish, the first tyrosine (Y) 
residue has been changed to phenylalanine (F). Since tyrosine and phenylalanine is 
structurally similar to each other, the function of this motif is not expected to be 
changed drastically. Also, the codon of tyrosine is UAU/C and phenylalanine is 
UUU/C. Therefore, the change may be due to a single mutation ofthe second codon U 
to A during the course of evolution. 
In the intracellular domain, the Box 1 region is found to be highly conserved in 
all GHRs. This region is necessary for the signal transduction of the Jak and Stat 
pathways of GHR (53-54). But in gfGHR, the Box 1 region has the two valines within 
this sequence changed. Instead of PPVPVP is most species, the sequence is PPIPAP 
in gfGHR. Since valine, alanine and isoleucine all carry non-polar side chain, this 
change is not expected to affect the charge of the Box 1 region. But further studies are 
necessary to identify the effect of this change. 
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The other conserved region in the intracellular domain is the Box 2 region. This 
region is responsible for mediating cell proliferation, lipogenesis and protein synthesis. 
Inside this region, the phenylalanine is necessary for GHR internalization (31) and 
down-regulation (83). The Box 2 region of gfGHR is also highly conserved. 
Especially, the sequence around the phenylalaine (WVEFI) is conserved in all GHRs. 
This suggests that this sequence is critical for GHR internalization and regulation. 
There are eight conserved tyrosine residues inside the intracellular domain of 
GHR. These conserved tyrosine residues have different functions, including the 
phosphorylation of intracellular proteins and for maximal Stat activation at tyrosine 
Y332 and Y337 (positions in rat) (90). Another three tyrosines, namely Y534, Y566 
and Y627 have been reported (83) to be involved in transcriptional signaling and are 
proposed to be the Stat 5 binding sites. In gfGHR, the Y332 and Y337, Y534 and 
Y627 are conserved. In the case of Y566, the tyrosine residue is not conserved in 
gfGHR. But two other tyrosine residues are found at gfGHR at positions 504 and 532. 
The difference in the positions and the presence of an additional tyrosine residue 
suggest that the transcriptional signaling of gfGHR may be different from other GHRs. 
The result of goldfish GHR tissue distribution (Section 5.3.4) shows the wide 
distribution of GHR in different organs, suggesting the diversified functions ofGH in 
fish. The liver of goldfish had the highest expression level of gfGHR. This suggests 
Page 141 
Chapter 5 Molecular Cloning 
and Functional Expression of gfGHR 
that the liver is the primary organ responding to GH, indicating that the gfGH might 
also stimulate hepatic IGF production in fish in order to mediate the indirect actions 
of GH. The expression level of hypothalamus was very high. Since the regulation of 
GH secretion is under the control of hypothalamus. The hypothalamus can release 
somatostatin to act on the pituitary and to down regulate the GH release. Therefore, 
the high expression level of gfGHR may be related to the down-regulation of GH 
secretion in the hypothalamus. The kidney, intestine and gill of goldfish also express 
GHR in significant amounts. The presence of GHR in kideny and gill suggests a 
possible role of GH in osmoregulation in fish. The high level of the expression in 
male gonad indicates the GH is an important factor in gonad ftmction. 
After the sequence of gfGHR has been obtained, the coding region of gfGHR 
is expressed in CH0-K1 using the pRc/CMV vector. The RT-PCR results of section 
5.3.5 shows that the mRNA of gfGHR is successfully transcribed in the CHO-GHR 
cell line. The biological fiinctions of the receptor has been tested by the proliferation 
assay and Spi luciferase assay. 
In the proliferation assay, different concentrations of hGH have been used to 
stimulate the growth of the CHO-GHR cells. The peak of increase in proliferation 
appears at the dose of 200ng/ml of hGH in the medium. At higher concentration, the 
increase of proliferation is dropped. This indicates the response of the gfGHR to GH 
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is saturated at high concentrations of GH. This result is similar to mammalian GHR 
suggesting the dimerization of two gfGHRs is required to induce the downstream 
signal transduction pathway (88). 
In the Spi luciferase assay (80), different GH preparations have been used to 
test their effects on gfGHR. The hGH has the highest stimulating effect on gfGHR. 
The gfGH I and gfGH II can also stimulate the response but the effect is lower. This 
result suggested that the mammalian GHs have higher potential to bind and stimulate 
the response of GHR in lower vertebrates. The response observed in gfGH I is higher 
than that of gfGH2. This difference may be due to the following reasons: 1. The 
gfGHl and gfGH II have different binding affinities. Therefore, in the same amount 
of GH, the effect is different; 2. Since the structures of the gfGH I and gfGH II are 
different, the conformation GH-GHR complex may be different, thus affecting the 
response to the downstream signal transduction pathway. 3. There are more then one 
form ofgfGHR in goldfish. The gfGHR found in this project is more specific to use 
gfGH I as the ligand. Further experiments, for example, binding assay of gfGH I and 
gfGH II to gfGHR and the expression level of gfGHs and gfGHR at different stages 
during development are required to support the hypotheses suggested above. 
In conclusion, a novel GHR sequence in fish was isolated from goldfish. A 
total of2540bp of gfGHR cDNA sequence was obtained. This sequence included the 
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5，UTR, 3'UTR and the complete coding region of gfGHR. The sequence of this 
receptor contained several characteristic of GHR when compared to other GHRs. 
However, the low homology of the intracellular domain, the additional Asn-
glycosylation site in the extracellular domain are missing conserved tyrosine residue 
and two additional un-conserved tyrosine residue in the intracellular domain. This 
suggests that the function of gfGHR may be different from other GHRs. Both the 
proliferation assay and the Spi luciferase assay suggested that gfGHR was 
functionally expressed on the transfected cells. In the proliferation assay, it indicates 
that the gfGHR response to GH is dose-dependent and the dimerization of gfGHR is 
required to induce the downstream signal transduction pathway. The difference of 
gfGH I and gfGH II in the luciferase assay demostrates the potential functional 
difference of this two GH isoforms. Further studies are required to identify this 
difference. The CHO-Kl cells expressing the gfGHR can act as a useful tool to study 
the interaction between fish GH and fish GHR action in the ftiture. 
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Chapter 6 General Discussion and future works 
6.1. General discussion 
The gfGHR, xGHR, xGH-A and xGH-B were identified in this project. By the 
sequences, we found that the xGH-A and xGH-B share many conserved regions to 
mammalian and avian GHR. This suggesting that the function of GH in amphibian is 
similar to the mammalian GH. Two GH isoforms in Xenopus laevis is quite different 
to each others (discussed in chapter 4). This kind bf isoform is not found in 
mammalian. In mammalian, the GH isoforms are usually sharing a high degree 
homology. Therefore, the possible functional different ofthese isoform may be related 
to the physiological different of amphibian than mammalian. Amphibians have two 
major growth periods: the larval period (pre- and prometamorphosis) and the juvenile 
period. During these two periods, GH and PRL have different degree of 
growth-promoting action (91). But the studies of GH effect on hypphysectomized 
frogs were based the usage of mammalian (92,93). Therefore, the results from these 
reports may be representing a part of the function of the amphibian GH. In the case of 
xGH-A and xGH-B, they may contain different functions in growth or metamorphosis. 
They may be expressed in different growth period and induced different growth 
properties. In the case of GHR, the sequence of xGHR and gfGHR also sharing many 
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conserved regions. However, in the case of gfGHR, the intracellular domain are 
different to others GHR. These different may be related to the osmoregulation of GH 
in fish. But the fish GHR signal transduction pathway was rarely studied, so the detail 
expansion cannot be made at this stage of studies. 
6.2. Future works 
6.2.1. Identification the function of xGH isoforms 
The xGHR expressing cell lines and the recombinant xGH-A and xGH-B 
provided a valuable tools to study the GH isoforms in lower vertebrate. The 
membrane of the xGHR cell line can be used in the receptor binding assay to test the 
binding affinity of the GH isoforms. Also the downstream signaling pathway different 
in two isoforms can be studied, by monitor the Jak2 phosphorylation and MAP kinase 
activity change in the stimulated cell lines. 
6.2.2. Signaling transduction pathway of gfGHR 
The Y627 is missing and tow addition tyrosine residue (Y504 and Y532) were 
found in the intracellular domain of gfGHR. Therefore, a mutation analysis of the 
gfGHR can be carried out to studies the signal transduction pathway of gfGHR. Since 
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Y627 may be a Stat 5 binding sites, the Stat5 protein phosphorylation should be tested 
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Xenopus laevis cDNA library 
Description: Xenopus laevis, outbred, adult, cloned unidirectionally 
Vector: Uni-ZAP XR 
Average insert size: 1.5kb 
Insert Size: >0.4kb 
Primer: Unidirectional oligo(dT) 
Cloning Site: EcoR I and Xho I 
Estimated Titer: 2.5 x 10^ ® pfu/ml 
Actin Screen: 0.17% 
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The alignment ofthe gfGHR primers design 
Region 1 
R ^ a TGG GTT GAG TTC ATA GAG CTC GA 
Xenopus TGG GTT GAA TTT ATT GAG CTC GA 
眺 TGG GTT GAG TTC ATT GAG CTG GA 
Chicken TGG GTT GAG TTT ATT GAA TTG GA 
Nucleotide TGG GTT GAR TTY ATW GAR YTS GA 
Amino acid TGG GTN GAR TTY AHW GAR YTN GA 
Region 2 
Rana GAT TCT GGC CGA GCC AGC TG 
Xenopus GAT TCT GGA CGA GCC AGC TG 
Rat GAT TCT GGA CGT ACC AGC TG 
Chicken GAT TCT GGA CGT GCC AGT TG 
Nucleotide GAT TCT GGM CGW RCC AGT TG 
Amino acid GAY WSN GGN MGN RCN RSN TG 
Region 3 
R _ GAC TTC TAT GCT CTT GTA AGT GAT ATC ACA CCA CCA 
Xenopus GAC TTC TAT GCT TTG GTT AGC GAC ATA ACT CCT GCA 
R ” 1 GAC TTT TAT GCC CAA GTA AGC GAC ATT ACA CCA GCA 
Chicken GAC TTC TAT GCT CAA GTG AGT GAT ATT ACT CCT GCT 
Nucleotide GAC TTY TAT GCY YWD GTD AGY GAY ATH ACW CCW GCW 
Amino acid GAY TTY TAY GCN YWD GTN WTN GAY ATH CAN CCN GCW 
Y = C + T 
R = G + A 
M = C + A 
H = A + T + C 
W = A + T 
S = C + G 
D = A + G + T 
K = G + T 
N = A + T + C + G 
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